Iwao Ojima - Publications

Affiliations: 
Chemistry Stony Brook University, Stony Brook, NY, United States 
Area:
Medicinal Chemistry
Website:
https://www.stonybrook.edu/commcms/chemistry/faculty/ojima.iwao.html

244/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Wang H, Taouil A, Awwa M, Clement T, Zhu C, Kim J, Rendina D, Jayanetti K, Maharaj A, Wang L, Bogdan D, Pepe A, Kaczocha M, Ojima I. SAR study on Novel truxillic acid monoester-Based inhibitors of fatty acid binding proteins as Next-Generation antinociceptive agents. Bioorganic Chemistry. 129: 106184. PMID 36244323 DOI: 10.1016/j.bioorg.2022.106184  0.506
2020 Rong D, Wang C, Zhang X, Wei Y, Zhang M, Liu D, Farhan H, Momen Ali SA, Liu Y, Taouil A, Guo W, Wang Y, Ojima I, Yang S, Wang H. A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells. Cancer Letters. PMID 32730778 DOI: 10.1016/J.Canlet.2020.06.025  0.345
2020 Lazzarini C, Haranahalli K, McCarthy JB, Mallamo J, Ojima I, Del Poeta M. Preclinical evaluation of acylhydrazone SB-AF-1002 as a novel broad-spectrum antifungal agent. Antimicrobial Agents and Chemotherapy. PMID 32601165 DOI: 10.1128/Aac.00946-20  0.324
2019 Wang C, Wang X, Sun Y, Taouil AK, Yan S, Botchkina GI, Ojima I. Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH, 3-CFO and 3-CHFO groups at the C2-benzoate position. Bioorganic Chemistry. 95: 103523. PMID 31911305 DOI: 10.1016/J.Bioorg.2019.103523  0.395
2019 Carbonetti G, Converso C, Clement T, Wang C, Trotman L, Ojima I, Kaczocha M. Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth. The Prostate. PMID 31661167 DOI: 10.1002/Pros.23921  0.322
2019 Haranahalli K, Honda T, Ojima I. Recent progress in the strategic incorporation of fluorine into medicinally active compounds. Journal of Fluorine Chemistry. 217: 29-40. PMID 31537946 DOI: 10.1016/J.Jfluchem.2018.11.002  0.367
2019 Haranahalli K, Lazzarini C, Sun Y, Zambito J, Pathiranage S, McCarthy JB, Mallamo JP, Del Poeta M, Ojima I. SAR Studies on Aromatic Acylhydrazone-Based Inhibitors of Fungal Sphingolipid Synthesis as Next-Generation Antifungal Agents. Journal of Medicinal Chemistry. PMID 31369263 DOI: 10.1021/Acs.Jmedchem.9B01004  0.356
2018 Teng YG, Chien CW, Chiou WH, Honda T, Ojima I. Construction of Fused Tropone Systems Through Intramolecular Rh(I)-Catalyzed Carbonylative [2+2+2+1] Cycloadditon of Triynes. Frontiers in Chemistry. 6: 401. PMID 30250840 DOI: 10.3389/Fchem.2018.00401  0.71
2018 Chien CW, Teng YG, Honda T, Ojima I. Synthesis of Colchicinoids and Allocolchicinoids through Rh(I)-catalyzed [2+2+2+1] and [2+2+2] Cycloadditions of o-Phenylenetriynes with and without CO. The Journal of Organic Chemistry. PMID 30129760 DOI: 10.1021/Acs.Joc.8B01608  0.592
2018 Yan S, Elmes MW, Tong S, Hu K, Awwa M, Teng GYH, Jing Y, Freitag M, Gan Q, Clement T, Wei L, Sweeney JM, Joseph OM, Che J, Carbonetti GS, ... ... Ojima I, et al. SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins. European Journal of Medicinal Chemistry. 154: 233-252. PMID 29803996 DOI: 10.1016/J.Ejmech.2018.04.050  0.321
2018 Jelínek M, Balušíková K, Daniel P, Němcová-Fürstová V, Kirubakaran P, Jaček M, Wei L, Wang X, Vondrášek J, Ojima I, Kovář J. Substituents at the C3' and C3'N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel. Toxicology and Applied Pharmacology. PMID 29625142 DOI: 10.1016/J.Taap.2018.04.002  0.311
2018 Yang CH, Wang C, Ojima I, Horwitz SB. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein. Journal of Natural Products. PMID 29517223 DOI: 10.1021/Acs.Jnatprod.7B01047  0.348
2018 Lazzarini C, Haranahalli K, Rieger R, Ananthula HK, Desai PB, Ashbaugh A, Linke MJ, Cushion MT, Ruzsicska B, Haley J, Ojima I, Del Poeta M. Acylhydrazones as antifungal agents targeting the synthesis of fungal sphingolipids. Antimicrobial Agents and Chemotherapy. PMID 29507066 DOI: 10.1128/Aac.00156-18  0.359
2018 Ojima I, Wang X, Jing Y, Wang C. Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery. Journal of Natural Products. PMID 29468872 DOI: 10.1021/Acs.Jnatprod.7B01012  0.418
2018 Seitz JD, Wang T, Vineberg JG, Honda T, Ojima I. Synthesis of a Next-Generation Taxoid by Rapid Methylation Amenable for 11C-Labeling. The Journal of Organic Chemistry. PMID 29441783 DOI: 10.1021/Acs.Joc.7B03284  0.804
2017 Wang T, Vineberg JG, Honda T, Ojima I. Design and synthesis of tumor-targeting theranostic drug conjugates for SPECT and PET imaging studies. Bioorganic Chemistry. 76: 458-467. PMID 29287255 DOI: 10.1016/J.Bioorg.2017.12.018  0.79
2017 Ojima I. Strategic Incorporation of Fluorine into Taxoid Anticancer Agents for Medicinal Chemistry and Chemical Biology Studies. Journal of Fluorine Chemistry. 198: 10-23. PMID 28824201 DOI: 10.1016/J.Jfluchem.2016.12.016  0.35
2017 Ahmad G, El Sadda R, Botchkina G, Ojima I, Egan J, Amiji M. Nanoemulsion Formulation of a Novel Taxoid DHA-SBT-1214 Inhibits Prostate Cancer Stem Cell-Induced Tumor Growth. Cancer Letters. PMID 28803993 DOI: 10.1016/J.Canlet.2017.08.004  0.329
2017 Ojima I, Awasthi D, Wei L, Haranahalli K. Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ. Journal of Fluorine Chemistry. 196: 44-56. PMID 28555087 DOI: 10.1016/J.Jfluchem.2016.07.020  0.388
2017 Jelinek M, Kabelova A, Sramek J, Seitz J, Ojima I, Kovar J. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Research. 37: 1581-1590. PMID 28373418 DOI: 10.21873/Anticanres.11488  0.547
2017 Zheng X, Wang C, Xing Y, Chen S, Meng T, You H, Ojima I, Dong Y. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells. International Journal of Oncology. PMID 28197640 DOI: 10.3892/Ijo.2017.3871  0.322
2016 Islam MM, Hameed HM, Mugweru J, Chhotaray C, Wang C, Tan Y, Liu J, Li X, Tan S, Ojima I, Yew WW, Nuermberger E, Lamichhane G, Zhang T. Drug resistance mechanisms and novel drug targets for tuberculosis therapy. Journal of Genetics and Genomics = Yi Chuan Xue Bao. PMID 28117224 DOI: 10.1016/J.Jgg.2016.10.002  0.318
2016 Haranahalli K, Tong S, Ojima I. Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ. Bioorganic & Medicinal Chemistry. PMID 27189886 DOI: 10.1016/J.Bmc.2016.05.003  0.347
2016 Yang CH, Wang C, Ojima I, Horwitz SB. Abstract 1229: The next-generation taxanes, SB-T-1214 and SB-CST-10202, exhibit distinct inhibitory effects on photolabeling of β-tubulin from different eukaryotic sources Cancer Research. 76: 1229-1229. DOI: 10.1158/1538-7445.Am2016-1229  0.341
2016 Afrimzon E, Botchkina G, Zurgil N, Shafran Y, Sobolev M, Moshkov S, Ravid-Hermesh O, Ojima I, Deutsch M. Hydrogel microstructure live-cell array for multiplexed analyses of cancer stem cells, tumor heterogeneity and differential drug response at single-element resolution Lab On a Chip - Miniaturisation For Chemistry and Biology. 16: 1047-1062. DOI: 10.1039/C6Lc00014B  0.344
2015 Ojima I, Lichtenthal B, Lee S, Wang C, Wang X. Taxane anticancer agents: a patent perspective. Expert Opinion On Therapeutic Patents. 1-20. PMID 26651178 DOI: 10.1517/13543776.2016.1111872  0.319
2015 Teng YH, Berger WT, Nesbitt NM, Kumar K, Balius TE, Rizzo RC, Tonge PJ, Ojima I, Swaminathan S. Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A. Bioorganic & Medicinal Chemistry. 23: 5489-95. PMID 26275678 DOI: 10.1016/J.Bmc.2015.07.040  0.723
2015 Mor V, Rella A, Farnoud AM, Singh A, Munshi M, Bryan A, Naseem S, Konopka JB, Ojima I, Bullesbach E, Ashbaugh A, Linke MJ, Cushion M, Collins M, Ananthula HK, et al. Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids. Mbio. 6. PMID 26106079 DOI: 10.1128/Mbio.00647-15  0.371
2015 Li W, Zheng S, Higgins M, Morra RP, Mendis AT, Chien CW, Ojima I, Mierke DF, Dinkova-Kostova AT, Honda T. New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide Synthase. Journal of Medicinal Chemistry. 58: 4738-48. PMID 25965897 DOI: 10.1021/Acs.Jmedchem.5B00393  0.605
2015 Seitz JD, Vineberg JG, Herlihy E, Park B, Melief E, Ojima I. Design, synthesis and biological evaluation of a highly-potent and cancer cell selective folate-taxoid conjugate. Bioorganic & Medicinal Chemistry. 23: 2187-94. PMID 25819334 DOI: 10.1016/J.Bmc.2015.02.057  0.812
2015 He Z, Schulz A, Wan X, Seitz J, Bludau H, Alakhova DY, Darr DB, Perou CM, Jordan R, Ojima I, Kabanov AV, Luxenhofer R. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 208: 67-75. PMID 25725361 DOI: 10.1016/J.Jconrel.2015.02.024  0.603
2015 Seitz JD, Vineberg JG, Wei L, Khan JF, Lichtenthal B, Lin CF, Ojima I. Design, Synthesis and Application of Fluorine-Labeled Taxoids as (19)F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery Systems. Journal of Fluorine Chemistry. 171: 148-161. PMID 25722499 DOI: 10.1016/J.Jfluchem.2014.08.006  0.787
2015 Elmes MW, Kaczocha M, Berger WT, Leung K, Ralph BP, Wang L, Sweeney JM, Miyauchi JT, Tsirka SE, Ojima I, Deutsch DG. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The Journal of Biological Chemistry. 290: 8711-21. PMID 25666611 DOI: 10.1074/Jbc.M114.618447  0.637
2015 Vineberg JG, Wang T, Zuniga ES, Ojima I. Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugates. Journal of Medicinal Chemistry. 58: 2406-16. PMID 25654690 DOI: 10.1021/Jm5019115  0.794
2015 Zang Y, Ojima I. Pd-catalyzed asymmetric allylic amination with BOP ligands and its applications to the synthesis of fused polycyclic alkaloids Tetrahedron Letters. 56: 3288-3292. DOI: 10.1016/J.Tetlet.2015.01.047  0.573
2014 Matesanz R, Trigili C, Rodríguez-Salarichs J, Zanardi I, Pera B, Nogales A, Fang WS, Jímenez-Barbero J, Canales A, Barasoain I, Ojima I, Díaz JF. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances. Bioorganic & Medicinal Chemistry. 22: 5078-90. PMID 25047938 DOI: 10.1016/J.Bmc.2014.05.048  0.305
2014 Rowehl RA, Burke S, Bialkowska AB, Pettet DW, Rowehl L, Li E, Antoniou E, Zhang Y, Bergamaschi R, Shroyer KR, Ojima I, Botchkina GI. Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells. Plos One. 9: e99091. PMID 24921652 DOI: 10.1371/Journal.Pone.0099091  0.322
2014 Vineberg JG, Zuniga ES, Kamath A, Chen YJ, Seitz JD, Ojima I. Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapy. Journal of Medicinal Chemistry. 57: 5777-91. PMID 24901491 DOI: 10.1021/Jm500631U  0.804
2014 Knudson SE, Kumar K, Awasthi D, Ojima I, Slayden RA. In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis. Tuberculosis (Edinburgh, Scotland). 94: 271-6. PMID 24746463 DOI: 10.1016/J.Tube.2014.03.007  0.312
2014 Park B, Awasthi D, Chowdhury SR, Melief EH, Kumar K, Knudson SE, Slayden RA, Ojima I. Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents. Bioorganic & Medicinal Chemistry. 22: 2602-12. PMID 24726304 DOI: 10.1016/J.Bmc.2014.03.035  0.646
2014 Kaczocha M, Rebecchi MJ, Ralph BP, Teng YH, Berger WT, Galbavy W, Elmes MW, Glaser ST, Wang L, Rizzo RC, Deutsch DG, Ojima I. Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. Plos One. 9: e94200. PMID 24705380 DOI: 10.1371/Journal.Pone.0094200  0.707
2014 Ojima I, Kumar K, Awasthi D, Vineberg JG. Drug discovery targeting cell division proteins, microtubules and FtsZ. Bioorganic & Medicinal Chemistry. 22: 5060-77. PMID 24680057 DOI: 10.1016/J.Bmc.2014.02.036  0.798
2014 Moriwaki H, Resch D, Li H, Ojima I, Takeda R, Aceña JL, Soloshonok V. Inexpensive chemical method for preparation of enantiomerically pure phenylalanine. Amino Acids. 46: 945-52. PMID 24385244 DOI: 10.1007/S00726-013-1656-0  0.33
2014 Lin CF, Chien CW, Ojima I. Enantioselective Pd-catalyzed tandem allylic alkylation reaction using monodentate phosphoramidite ligands for the formal total synthesis of huperzine A Organic Chemistry Frontiers. 1: 1062-1066. DOI: 10.1039/C4Qo00180J  0.727
2014 Ojima I, Kamath A, Seitz JD. Taxol, Taxoids, and Related Taxanes Natural Products in Medicinal Chemistry. 127-180. DOI: 10.1002/9783527676545.ch04  0.438
2013 Awasthi D, Kumar K, Knudson SE, Slayden RA, Ojima I. SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents. Journal of Medicinal Chemistry. 56: 9756-70. PMID 24266862 DOI: 10.1021/Jm401468W  0.341
2013 Botchkina GI, Zuniga ES, Rowehl RH, Park R, Bhalla R, Bialkowska AB, Johnson F, Golub LM, Zhang Y, Ojima I, Shroyer KR. Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24. Plos One. 8: e69884. PMID 24086245 DOI: 10.1371/Journal.Pone.0069884  0.781
2013 Seitz J, Vineberg JG, Zuniga ES, Ojima I. Fluorine-Containing Taxoid Anticancer Agents and Their Tumor-Targeted Drug Delivery. Journal of Fluorine Chemistry. 152: 157-165. PMID 23935213 DOI: 10.1016/J.Jfluchem.2013.05.013  0.798
2013 Kumar K, Awasthi D, Lee SY, Cummings JE, Knudson SE, Slayden RA, Ojima I. Benzimidazole-based antibacterial agents against Francisella tularensis. Bioorganic & Medicinal Chemistry. 21: 3318-26. PMID 23623254 DOI: 10.1016/J.Bmc.2013.02.059  0.714
2013 Zang Y, Ojima I. Pd-catalyzed asymmetric allylic etherification using chiral biphenol-based diphosphinite ligands and its application for the formal total synthesis of (-)-galanthamine. The Journal of Organic Chemistry. 78: 4013-8. PMID 23472673 DOI: 10.1021/Jo400355J  0.57
2013 Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I, Deutsch DG. High throughput fluorescence displacement assay with NBD-stearate. Plos One. DOI: 10.1371/Journal.Pone.0050968.G008  0.6
2013 Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I, Deutsch DG. Scheme demonstrating anandamide inactivation and FABP drug target. Plos One. DOI: 10.1371/Journal.Pone.0050968.G001  0.641
2013 Zheng S, Chowdhury A, Ojima I, Honda T. Microwave-assisted Diels-Alder reactions between Danishefsky's diene and derivatives of ethyl α-(hydroxymethyl)acrylate. Synthetic approach toward a biotinylated anti-inflammatory monocyclic cyanoenone Tetrahedron. 69: 2052-2055. DOI: 10.1016/J.Tet.2012.12.079  0.309
2013 Ojima I, Athan A, Commandeur C, Chiou WH. Amidocarbonylation, Cyclohydrocarbonylation, and Related Reactions Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. DOI: 10.1016/B978-0-12-409547-2.03980-9  0.784
2012 Kamath A, Ojima I. Advances in the chemistry of β-lactam and its medicinal applications. Tetrahedron. 68: 10640-10664. PMID 23264702 DOI: 10.1016/J.Tet.2012.07.090  0.335
2012 Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I, Deutsch DG. Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs. Plos One. 7: e50968. PMID 23236415 DOI: 10.1371/Journal.Pone.0050968  0.662
2012 Kuznetsova L, Sun L, Chen J, Zhao X, Seitz J, Das M, Li Y, Veith JM, Pera P, Bernacki RJ, Xia S, Horwitz SB, Ojima I. Synthesis and Biological Evaluation of Novel 3'-Difluorovinyl Taxoids. Journal of Fluorine Chemistry. 143: 177-188. PMID 23139432 DOI: 10.1016/J.Jfluchem.2012.07.007  0.798
2012 Ehrlichová M, Ojima I, Chen J, Václavíková R, N?mcová-Fürstová V, Vobo?ilová J, Simek P, Horský S, Sou?ek P, Ková? J, Brabec M, Gut I. Transport, metabolism, cytotoxicity and effects of novel taxanes on the cell cycle in MDA-MB-435 and NCI/ADR-RES cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 385: 1035-48. PMID 22855252 DOI: 10.1007/S00210-012-0785-4  0.325
2012 Zheng S, Santosh Laxmi YR, David E, Dinkova-Kostova AT, Shiavoni KH, Ren Y, Zheng Y, Trevino I, Bumeister R, Ojima I, Wigley WC, Bliska JB, Mierke DF, Honda T. Synthesis, chemical reactivity as Michael acceptors, and biological potency of monocyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents. Journal of Medicinal Chemistry. 55: 4837-46. PMID 22533790 DOI: 10.1021/Jm3003922  0.308
2012 Ojima I, Zuniga ES, Berger WT, Seitz JD. Tumor-targeting drug delivery of new-generation taxoids. Future Medicinal Chemistry. 4: 33-50. PMID 22168163 DOI: 10.4155/Fmc.11.167  0.799
2012 Ojima I, Delaloge F. Syntheses of Norstatine, Its Analogs, and Dipeptide Isosteres by Means of β-Lactam Synthon Method. Methods in Molecular Medicine. 23: 137-60. PMID 21380896 DOI: 10.1385/0-89603-517-4:137  0.301
2012 Ehrlichova M, Vaclavikova R, Brynychova V, Nemcova V, Pecha V, Mrhalova M, Rob R, Ojima I, Gut I, Soucek P. 1045 Efficiency and Transport of Taxanes in Human Cancer Cell Lines and Solid Tumors European Journal of Cancer. 48: S252. DOI: 10.1016/S0959-8049(12)71656-8  0.308
2011 Lin CF, Ojima I. Formal enantioselective total synthesis of schulzeines A-C via Pd-catalyzed intramolecular asymmetric allylic amination. The Journal of Organic Chemistry. 76: 6240-9. PMID 21671593 DOI: 10.1021/Jo2009615  0.629
2011 Banerjee PS, Zuniga ES, Ojima I, Carrico IS. Targeted and armed oncolytic adenovirus via chemoselective modification. Bioorganic & Medicinal Chemistry Letters. 21: 4985-8. PMID 21669527 DOI: 10.1016/J.Bmcl.2011.05.039  0.765
2011 Awasthi D, Kumar K, Ojima I. Therapeutic potential of FtsZ inhibition: a patent perspective. Expert Opinion On Therapeutic Patents. 21: 657-79. PMID 21413908 DOI: 10.1517/13543776.2011.568483  0.335
2011 Shi C, Chien CW, Ojima I. Synthesis of chiral biphenol-based diphosphonite ligands and their application in palladium-catalyzed intermolecular asymmetric allylic amination reactions. Chemistry, An Asian Journal. 6: 674-80. PMID 21254441 DOI: 10.1002/Asia.201000697  0.61
2011 Kumar K, Awasthi D, Lee SY, Zanardi I, Ruzsicska B, Knudson S, Tonge PJ, Slayden RA, Ojima I. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents. Journal of Medicinal Chemistry. 54: 374-81. PMID 21126020 DOI: 10.1021/Jm1012006  0.746
2011 Vobořilová J, Němcová-Fürstová V, Neubauerová J, Ojima I, Zanardi I, Gut I, Kovář J. Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells Investigational New Drugs. 29: 411-423. PMID 20013348 DOI: 10.1007/S10637-009-9368-8  0.314
2011 Ojima I. Tumor-targeting drug delivery of chemotherapeutic agents Pure and Applied Chemistry. 83: 1685-1698. DOI: 10.1351/Pac-Con-11-02-10  0.377
2011 Chien CW, Shi C, Lin CF, Ojima I. Enantioselective synthesis of 1-vinyltetrahydroisoquinolines via Pd-catalyzed intramolecular asymmetric allylic amination reactions Tetrahedron. 67: 6513-6523. DOI: 10.1016/J.Tet.2011.05.125  0.719
2011 Seitz J, Ojima I. Drug Conjugates with Polyunsaturated Fatty Acids Drug Delivery in Oncology: From Basic Research to Cancer Therapy. 3: 1323-1357. DOI: 10.1002/9783527634057.ch41  0.499
2010 Kumar K, Awasthi D, Berger WT, Tonge PJ, Slayden RA, Ojima I. Discovery of anti-TB agents that target the cell-division protein FtsZ. Future Medicinal Chemistry. 2: 1305-23. PMID 21339840 DOI: 10.4155/Fmc.10.220  0.668
2010 Sun L, Veith JM, Pera P, Bernacki RJ, Ojima I. Design and synthesis of de novo cytotoxic alkaloids by mimicking the bioactive conformation of paclitaxel. Bioorganic & Medicinal Chemistry. 18: 7101-12. PMID 20800500 DOI: 10.1016/J.Bmc.2010.07.069  0.366
2010 Botchkina GI, Zuniga ES, Das M, Wang Y, Wang H, Zhu S, Savitt AG, Rowehl RA, Leyfman Y, Ju J, Shroyer K, Ojima I. New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Molecular Cancer. 9: 192. PMID 20630067 DOI: 10.1186/1476-4598-9-192  0.789
2010 Chen S, Zhao X, Chen J, Chen J, Kuznetsova L, Wong SS, Ojima I. Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release. Bioconjugate Chemistry. 21: 979-87. PMID 20429547 DOI: 10.1021/Bc9005656  0.706
2010 Botchkina GI, Ju J, Savitt AG, Rowehl RA, Zuniga E, Das M, Wang H, Zhu S, Ojima I. Abstract 3331: New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in colon and prostate CSCs Cancer Research. 70: 3331-3331. DOI: 10.1158/1538-7445.Am10-3331  0.784
2010 Ji JX, Chan ASC, Helmchen G, Kazmaier U, Förster S, Ojima I, Kaloko JJ, Chaterpaul SJ, Teng YHG, Lin CF, Mikami K, Aikawa K, Hoveyda AH, Malcolmson SJ, Meek SJ, et al. Asymmetric Carbon-Carbon Bond-Forming Reactions Catalytic Asymmetric Synthesis: Third Edition. 437-770. DOI: 10.1002/9780470584248.ch8  0.75
2009 DAS M, Zuniga E, Ojima I. Novel Taxoid-Based Tumor-Targeting Drug Conjugates. Chimica Oggi. 27: 54-56. PMID 21822353  0.805
2009 Ojima I. Medicinal chemistry at a crossroads: challenges and new possibilities. Future Medicinal Chemistry. 1: 401-3. PMID 21426118 DOI: 10.4155/Fmc.09.37  0.314
2009 Kaloko JJ, Teng YH, Ojima I. One-step formation of fused tetracyclic skeletons from cyclohexene-diynes and carbon monoxide through Rh(I)-catalyzed [2 + 2 + 2 + 1] cycloaddition reaction. Chemical Communications (Cambridge, England). 4569-71. PMID 19617986 DOI: 10.1039/B909781C  0.787
2009 Chiou WH, Lin GH, Hsu CC, Chaterpaul SJ, Ojima I. Efficient syntheses of crispine A and harmicine by RH-catalyzed cyclohydrocarbonylation. Organic Letters. 11: 2659-62. PMID 19456145 DOI: 10.1021/Ol900702T  0.789
2009 Pepe A, Sun L, Zanardi I, Wu X, Ferlini C, Fontana G, Bombardelli E, Ojima I. Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III beta-tubulin. Bioorganic & Medicinal Chemistry Letters. 19: 3300-4. PMID 19423340 DOI: 10.1016/J.Bmcl.2009.04.070  0.702
2009 Sun L, Simmerling C, Ojima I. Recent advances in the study of the bioactive conformation of taxol. Chemmedchem. 4: 719-31. PMID 19360801 DOI: 10.1002/Cmdc.200900044  0.331
2009 Ojima I, Das M. Recent advances in the chemistry and biology of new generation taxoids. Journal of Natural Products. 72: 554-65. PMID 19239240 DOI: 10.1021/Np8006556  0.634
2009 Gut I, Vaclavikova R, Ehrlichova M, Ojima I, Otova B, Hrdy J, Kovar J, Voborilova J, Nemcova V, Zanardi I. Abstract B9: Role of disposition, transport, in vitro efficiency and expression of relevant genes in the effects of novel taxanes on subcutaneous lymphoma in Sprague‐Dawley/Cub rats Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B9  0.358
2009 Gut I, Ehrlichova M, Vaclavikova R, Ojima I, Simek P. Abstract A147: Novel fluorinated taxane SB‐T‐12854 active in drug‐resistant and sensitive cell lines: Human, pig, rat metabolism, cell transport, and effects on cell cycle Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A147  0.305
2009 Pepe A, Sun L, Zanardi I, Wu X, Ferlini C, Fontana G, Bombardelli E, Ojima I. ChemInform Abstract: Novel C-Seco-Taxoids Possessing High Potency Against Paclitaxel-Resistant Cancer Cell Lines Overexpressing Class III β-Tubulin. Cheminform. 40. DOI: 10.1002/chin.200944181  0.67
2009 Pepe A, Kuznetsova L, Sun L, Ojima I. Fluoro-Taxoid Anticancer Agents Fluorine in Medicinal Chemistry and Chemical Biology. 117-139. DOI: 10.1002/9781444312096.ch5  0.633
2009 Ojima I, Li Z, Zhu J. Recent Advances in the Hydrosilylation and Related Reactions Patai's Chemistry of Functional Groups. 1687-1792. DOI: 10.1002/9780470682531.Pat0191  0.331
2009 Ojima I, Das M, Zuniga E. Novel taxoid-based tumour-targeting drug conjugates Chimica Oggi. 27: 54-56.  0.788
2008 Chiou WH, Schoenfelder A, Mann A, Ojima I. Application of Rhodium-Catalyzed Cyclohydrocarbonylation to the Syntheses of Enantiopure Homokainoids. Pure and Applied Chemistry. Chimie Pure Et Appliquee. 80: 1019-1024. PMID 19693284 DOI: 10.1351/Pac200880051019  0.61
2008 Chen J, Chen S, Zhao X, Kuznetsova LV, Wong SS, Ojima I. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. Journal of the American Chemical Society. 130: 16778-85. PMID 19554734 DOI: 10.1021/Ja805570F  0.714
2008 Kuznetsova LV, Pepe A, Ungureanu IM, Pera P, Bernacki RJ, Ojima I. Syntheses and Structure-Activity Relationships of Novel 3'-Difluoromethyl and 3'-Trifluoromethyl-Taxoids. Journal of Fluorine Chemistry. 129: 817-828. PMID 19448839 DOI: 10.1016/J.Jfluchem.2008.05.013  0.708
2008 Sun L, Geng X, Geney R, Li Y, Simmerling C, Li Z, Lauher JW, Xia S, Horwitz SB, Veith JM, Pera P, Bernacki RJ, Ojima I. Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoids. The Journal of Organic Chemistry. 73: 9584-93. PMID 18975909 DOI: 10.1021/Jo801713Q  0.805
2008 Respicio L, Nair PA, Huang Q, Anil B, Tracz S, Truglio JJ, Kisker C, Raleigh DP, Ojima I, Knudson DL, Tonge PJ, Slayden RA. Characterizing septum inhibition in Mycobacterium tuberculosis for novel drug discovery. Tuberculosis (Edinburgh, Scotland). 88: 420-9. PMID 18479968 DOI: 10.1016/J.Tube.2008.03.001  0.327
2008 Ojima I, Chen J, Sun L, Borella CP, Wang T, Miller ML, Lin S, Geng X, Kuznetsova L, Qu C, Gallager D, Zhao X, Zanardi I, Xia S, Horwitz SB, et al. Design, synthesis, and biological evaluation of new-generation taxoids. Journal of Medicinal Chemistry. 51: 3203-21. PMID 18465846 DOI: 10.1021/Jm800086E  0.798
2008 Ojima I. Modern natural products chemistry and drug discovery. Journal of Medicinal Chemistry. 51: 2587-8. PMID 18393400 DOI: 10.1021/Jm701291U  0.303
2008 Xu H, Sullivan TJ, Sekiguchi J, Kirikae T, Ojima I, Stratton CF, Mao W, Rock FL, Alley MR, Johnson F, Walker SG, Tonge PJ. Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus. Biochemistry. 47: 4228-36. PMID 18335995 DOI: 10.1021/Bi800023A  0.317
2008 Ojima I. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads. Accounts of Chemical Research. 41: 108-19. PMID 17663526 DOI: 10.1021/Ar700093F  0.387
2007 Chiou WH, Schoenfelder A, Sun L, Mann A, Ojima I. Rhodium-catalyzed cyclohydrocarbonylation approach to the syntheses of enantiopure homokainoids. The Journal of Organic Chemistry. 72: 9418-25. PMID 17999516 DOI: 10.1021/Jo070942N  0.619
2007 Huang Q, Tonge PJ, Slayden RA, Kirikae T, Ojima I. FtsZ: a novel target for tuberculosis drug discovery. Current Topics in Medicinal Chemistry. 7: 527-43. PMID 17346197 DOI: 10.2174/156802607780059790  0.363
2007 Chiou WH, Mizutani N, Ojima I. Highly efficient synthesis of azabicyclo[x.y.0]alkane amino acids and congeners by means of Rh-catalyzed cyclohydrocarbonylation. The Journal of Organic Chemistry. 72: 1871-82. PMID 17346029 DOI: 10.1021/Jo061692Y  0.628
2007 Shi C, Ojima I. Asymmetric synthesis of 1-vinyltetrahydroisoquinoline through Pd-catalyzed intramolecular allylic amination Tetrahedron. 63: 8563-8570. DOI: 10.1016/J.Tet.2007.04.097  0.326
2007 Ojima I, Kuznetsova LV, Sun L. Organofluorine chemistry at the biomedical interface: A case study on fluoro-taxoid anticancer agents Acs Symposium Series. 949: 288-304.  0.475
2006 Gut I, Ojima I, Vaclavikova R, Simek P, Horsky S, Linhart I, Soucek P, Kondrova E, Kuznetsova LV, Chen J. Metabolism of new-generation taxanes in human, pig, minipig and rat liver microsomes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 36: 772-92. PMID 16971343 DOI: 10.1080/00498250600829220  0.527
2006 Chapsal BD, Ojima I. Total synthesis of enantiopure (+)-gamma-lycorane using highly efficient Pd-catalyzed asymmetric allylic alkylation. Organic Letters. 8: 1395-8. PMID 16562900 DOI: 10.1021/Ol060181V  0.796
2006 Huang Q, Kirikae F, Kirikae T, Pepe A, Amin A, Respicio L, Slayden RA, Tonge PJ, Ojima I. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents. Journal of Medicinal Chemistry. 49: 463-6. PMID 16420032 DOI: 10.1021/Jm050920Y  0.595
2006 Kuznetsova L, Chen J, Sun L, Wu X, Pepe A, Veith JM, Pera P, Bernacki RJ, Ojima I. Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents. Bioorganic & Medicinal Chemistry Letters. 16: 974-7. PMID 16298526 DOI: 10.1016/J.Bmcl.2005.10.089  0.772
2006 Ojima I, Chapsal B. Total Synthesis of (+)-γ-Lycorane Synfacts. 2006: 0864-0864. DOI: 10.1055/s-2006-942051  0.768
2006 Chapsal BD, Hua Z, Ojima I. Catalytic asymmetric transformations with fine-tunable biphenol-based monodentate ligands Tetrahedron Asymmetry. 17: 642-657. DOI: 10.1016/J.Tetasy.2005.12.035  0.779
2005 Geney R, Chen J, Ojima I. Recent advances in the new generation taxane anticancer agents. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 1: 125-39. PMID 16787308 DOI: 10.2174/1573406053175292  0.811
2005 Bennacer B, Fujiwara M, Lee SY, Ojima I. Silicon-initiated carbonylative carbotricyclization and [2+2+2+1] cycloaddition of enediynes catalyzed by rhodium complexes. Journal of the American Chemical Society. 127: 17756-67. PMID 16351104 DOI: 10.1021/Ja054221M  0.744
2005 Chen J, Jaracz S, Zhao X, Chen S, Ojima I. Antibody-cytotoxic agent conjugates for cancer therapy. Expert Opinion On Drug Delivery. 2: 873-90. PMID 16296784 DOI: 10.1517/17425247.2.5.873  0.566
2005 Ehrlichova M, Vaclavikova R, Ojima I, Pepe A, Kuznetsova LV, Chen J, Truksa J, Kovar J, Gut I. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 372: 95-105. PMID 16059735 DOI: 10.1007/S00210-005-1080-4  0.691
2005 Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorganic & Medicinal Chemistry. 13: 5043-54. PMID 15955702 DOI: 10.1016/J.Bmc.2005.04.084  0.616
2005 Geney R, Sun L, Pera P, Bernacki RJ, Xia S, Horwitz SB, Simmerling CL, Ojima I. Use of the tubulin bound paclitaxel conformation for structure-based rational drug design. Chemistry & Biology. 12: 339-48. PMID 15797218 DOI: 10.1016/J.Chembiol.2005.01.004  0.8
2005 Ojima I, Borella CP, Wu X, Bounaud PY, Oderda CF, Sturm M, Miller ML, Chakravarty S, Chen J, Huang Q, Pera P, Brooks TA, Baer MR, Bernacki RJ. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents. Journal of Medicinal Chemistry. 48: 2218-28. PMID 15771464 DOI: 10.1021/Jm049483Y  0.786
2005 Chiou WH, Lee SY, Ojima I. Recent advances in cyclohydrocarbonylation reactions Canadian Journal of Chemistry. 83: 681-692. DOI: 10.1139/V05-035  0.789
2004 Bennacer B, Fujiwara M, Ojima I. Novel [2 + 2 + 2 + 1] cycloaddition of enediynes catalyzed by rhodium complexes. Organic Letters. 6: 3589-91. PMID 15387555 DOI: 10.1021/Ol048500A  0.347
2004 Choi H, Hua Z, Ojima I. Highly enantioselective copper-catalyzed conjugate addition of diethylzinc to nitroalkenes. Organic Letters. 6: 2689-91. PMID 15281745 DOI: 10.1021/Ol0491282  0.636
2004 Miller ML, Roller EE, Wu X, Leece BA, Goldmacher VS, Chari RV, Ojima I. Synthesis of potent taxoids for tumor-specific delivery using monoclonal antibodies. Bioorganic & Medicinal Chemistry Letters. 14: 4079-82. PMID 15225730 DOI: 10.1016/J.Bmcl.2004.05.027  0.578
2004 Geng X, Geney R, Pera P, Bernacki RJ, Ojima I. Design and synthesis of de novo cytotoxic alkaloids through mimicking taxoid skeleton. Bioorganic & Medicinal Chemistry Letters. 14: 3491-4. PMID 15177459 DOI: 10.1016/J.Bmcl.2004.04.060  0.788
2004 Minderman H, Brooks TA, O'Loughlin KL, Ojima I, Bernacki RJ, Baer MR. Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023. Cancer Chemotherapy and Pharmacology. 53: 363-9. PMID 15060738 DOI: 10.1007/S00280-003-0745-2  0.311
2004 Hua Z, Vassar VC, Choi H, Ojima I. New biphenol-based, fine-tunable monodentate phosphoramidite ligands for catalytic asymmetric transformations. Proceedings of the National Academy of Sciences of the United States of America. 101: 5411-6. PMID 15020764 DOI: 10.1073/Pnas.0307101101  0.612
2004 Wu X, Ojima I. Tumor specific novel taxoid-monoclonal antibody conjugates. Current Medicinal Chemistry. 11: 429-38. PMID 14965224 DOI: 10.2174/0929867043455963  0.563
2004 Kuznetsova L, Ungureanu IM, Pepe A, Zanardi I, Wu X, Ojima I. Trifluoromethyl- and difluoromethyl-β-lactams as useful building blocks for the synthesis of fluorinated amino acids, dipeptides, and fluoro-taxoids Journal of Fluorine Chemistry. 125: 487-500. DOI: 10.1016/J.Jfluchem.2003.12.001  0.739
2003 Hua Z, Vassar VC, Ojima I. Synthesis of new chiral monodentate phosphite ligands and their use in catalytic asymmetric hydrogenation. Organic Letters. 5: 3831-4. PMID 14535721 DOI: 10.1021/Ol035343R  0.627
2003 Geng X, Miller ML, Lin S, Ojima I. Synthesis of novel C2-C3'N-linked macrocyclic taxoids by means of highly regioselective Heck macrocyclization. Organic Letters. 5: 3733-6. PMID 14507217 DOI: 10.1021/Ol0354627  0.574
2003 Ojima I, Geney R. 109881 Aventis. Current Opinion in Investigational Drugs (London, England : 2000). 4: 737-40. PMID 12901234  0.759
2003 Ojima I, Geney R. BMS-184476 Bristol-Myers Squibb. Current Opinion in Investigational Drugs (London, England : 2000). 4: 732-6. PMID 12901233  0.758
2003 Ojima I, Ferlini C. New insights into drug resistance in cancer. Chemistry & Biology. 10: 583-4. PMID 12890528 DOI: 10.1016/S1074-5521(03)00152-2  0.33
2003 Ferlini C, Ojima I, Distefano M, Gallo D, Riva A, Morazzoni P, Bombardelli E, Mancuso S, Scambia G. Second generation taxanes: from the natural framework to the challenge of drug resistance. Current Medicinal Chemistry. Anti-Cancer Agents. 3: 133-8. PMID 12678907 DOI: 10.2174/1568011033353489  0.372
2003 Ojima I, Tsai C, Tzamarioudaki M, Bonafoux D. The Hydroformylation Reaction Cheminform. 34. DOI: 10.1002/0471264180.Or056.01  0.311
2002 Mizutani N, Chiou WH, Ojima I. New and efficient synthesis of azabicyclo[4.4.0]alkane amino acids by Rh-catalyzed cyclohydrocarbonylation. Organic Letters. 4: 4575-8. PMID 12489933 DOI: 10.1021/Ol026782D  0.616
2002 Ojima I, Geng X, Wu X, Qu C, Borella CP, Xie H, Wilhelm SD, Leece BA, Bartle LM, Goldmacher VS, Chari RV. Tumor-specific novel taxoid-monoclonal antibody conjugates. Journal of Medicinal Chemistry. 45: 5620-3. PMID 12477344 DOI: 10.1021/Jm025540G  0.776
2002 Geney R, Ungureanu lM, Li D, Ojima I. Overcoming multidrug resistance in taxane chemotherapy. Clinical Chemistry and Laboratory Medicine. 40: 918-25. PMID 12435109 DOI: 10.1515/Cclm.2002.161  0.807
2002 Ojima I, Vu AT, Lee SY, McCullagh JV, Moralee AC, Fujiwara M, Hoang TH. Rhodium-catalyzed silylcarbocyclization (SiCaC) and carbonylative silylcarbocyclization (CO-SiCaC) reactions of enynes. Journal of the American Chemical Society. 124: 9164-74. PMID 12149021 DOI: 10.1021/Ja0258982  0.743
2002 Ojima I, Geney R, Ungureanu IM, Li D. Medicinal chemistry and chemical biology of new generation taxane antitumor agents. Iubmb Life. 53: 269-74. PMID 12121008 DOI: 10.1080/15216540212658  0.805
2002 Jordan MA, Ojima I, Rosas F, Distefano M, Wilson L, Scambia G, Ferlini C. Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis. Chemistry & Biology. 9: 93-101. PMID 11841942 DOI: 10.1016/S1074-5521(01)00097-7  0.335
2002 Chuang CY, Vassar VC, Ma Z, Geney R, Ojima I. Electronic effects on the regio- and enantioselectivity of the asymmetric aminohydroxylation of O-substituted 4-hydroxy-2-butenoates. Chirality. 14: 151-62. PMID 11835558 DOI: 10.1002/Chir.10050  0.782
2002 Ojima I, Geng X, Lin S, Pera P, Bernacki RJ. Design, synthesis and biological activity of novel C2-C3' N-Linked macrocyclic taxoids. Bioorganic & Medicinal Chemistry Letters. 12: 349-52. PMID 11814794 DOI: 10.1016/S0960-894X(01)00747-8  0.577
2002 Ojima I. New cyclization reactions in organic syntheses Pure and Applied Chemistry. 74: 159-166. DOI: 10.1351/Pac200274010159  0.361
2002 Ojima I, Moralee AC, Vassar VC. Topics in Catalysis. 19: 89-99. DOI: 10.1023/A:1013837417361  0.318
2001 Miller ML, Ojima I. Chemistry and chemical biology of taxane anticancer agents. Chemical Record (New York, N.Y.). 1: 195-211. PMID 11895119 DOI: 10.1002/Tcr.1008  0.409
2001 Chibale K, Ojima I, Haupt H, Geng X, Pera P, Bernacki RJ. Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides. Bioorganic & Medicinal Chemistry Letters. 11: 2457-60. PMID 11549446 DOI: 10.1016/S0960-894X(01)00462-0  0.604
2001 Vredenburg MR, Ojima I, Veith J, Pera P, Kee K, Cabral F, Sharma A, Kanter P, Greco WR, Bernacki RJ. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. Journal of the National Cancer Institute. 93: 1234-45. PMID 11504769 DOI: 10.1093/Jnci/93.16.1234  0.349
2001 Crabtree DV, Ojima I, Geng X, Adler AJ. Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site. Bioorganic & Medicinal Chemistry. 9: 1967-76. PMID 11504633 DOI: 10.1016/S0968-0896(01)00103-1  0.512
2001 Bonafoux D, Hua Z, Wang B, Ojima I. Design and synthesis of new fluorinated ligands for the rhodium-catalyzed hydroformylation of alkenes in supercritical CO2 and fluorous solvents Journal of Fluorine Chemistry. 112: 101-108. DOI: 10.1016/S0022-1139(01)00473-0  0.599
2000 Ferlini C, Distefano M, Pignatelli F, Lin S, Riva A, Bombardelli E, Mancuso S, Ojima I, Scambia G. Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors British Journal of Cancer. 83: 1762-1768. PMID 11104578 DOI: 10.1054/Bjoc.2000.1500  0.341
2000 Ojima I, Lin S, Slater JC, Wang T, Pera P, Bernacki RJ, Ferlini C, Scambia G. Syntheses and biological activity of C-3'-difluoromethyl-taxoids. Bioorganic & Medicinal Chemistry. 8: 1619-28. PMID 10976509 DOI: 10.1016/S0968-0896(00)00093-6  0.379
2000 Lin S, Geng X, Qu C, Tynebor R, Gallagher DJ, Pollina E, Rutter J, Ojima I. Synthesis of highly potent second-generation taxoids through effective kinetic resolution coupling of racemic beta-lactams with baccatins. Chirality. 12: 431-41. PMID 10824166 DOI: 10.1002/(Sici)1520-636X(2000)12:5/6<431::Aid-Chir24>3.0.Co;2-M  0.566
2000 Lin S, Ojima I. Recent strategies in the development of taxane anticancer drugs Expert Opinion On Therapeutic Patents. 10: 869-889. DOI: 10.1517/13543776.10.6.869  0.381
2000 Ojima I, Lee SY. Rhodium-catalyzed novel carbonylative carbotricyclization of enediynes [8] Journal of the American Chemical Society. 122: 2385-2386. DOI: 10.1021/Ja993977G  0.751
2000 Ojima I, Lin S, Inoue T, Miller ML, Borella CP, Geng X, Walsh JJ. Macrocycle formation by ring-closing metathesis. Application to the syntheses of novel macrocyclic taxoids Journal of the American Chemical Society. 122: 5343-5353. DOI: 10.1021/Ja000293W  0.799
1999 Ojima I, Wang T, Miller ML, Lin S, Borella CP, Geng X, Pera P, Bernacki RJ. Synthesis and structure-activity relationships of new second-generation taxoids. Bioorganic & Medicinal Chemistry Letters. 9: 3423-8. PMID 10617084 DOI: 10.1016/S0960-894X(99)00629-0  0.803
1999 Ojima I, Chakravarty S, Inoue T, Lin S, He L, Horwitz SB, Kuduk SD, Danishefsky SJ. A common pharmacophore for cytotoxic natural products that stabilize microtubules Proceedings of the National Academy of Sciences of the United States of America. 96: 4256-4261. PMID 10200249 DOI: 10.1073/Pnas.96.8.4256  0.325
1999 Nakano M, Tominaga K, Saito S, Kirikae F, Lin S, Fumero CL, Ojima I, Kirikae T. Lipopolysaccharide- and paclitaxel (Taxol)-induced tolerance in murine peritoneal macrophages Innate Immunity. 5: 102-106. DOI: 10.1177/09680519990050011201  0.745
1999 Ojima I, Vidal ES. Extremely Regioselective Intramolecular Silylformylation of Bis(silylamino)alkynes Organometallics. 18: 5103-5107. DOI: 10.1021/Om9904549  0.318
1999 Ojima I, Vu AT, McCullagh JV, Kinoshita A. Rhodium-catalyzed intramolecular silylcarbotricyclization (SiCaT) of triynes [7] Journal of the American Chemical Society. 121: 3230-3231. DOI: 10.1021/Ja9815529  0.335
1999 Ojima I, Inoue T, Chakravarty S. Enantiopure fluorine-containing taxoids: Potent anticancer agents and versatile probes for biomedical problems Journal of Fluorine Chemistry. 97: 3-10. DOI: 10.1016/S0022-1139(99)00058-5  0.371
1998 Ojima I, Bounaud PY, Takeuchi C, Pera P, Bernacki RJ. New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells. Bioorganic & Medicinal Chemistry Letters. 8: 189-94. PMID 9871652 DOI: 10.1016/S0960-894X(97)10218-9  0.385
1998 Ojima I, Bounaud P, Oderda CF. Recent strategies for the treatment of multi-drug resistance in cancer cells Expert Opinion On Therapeutic Patents. 8: 1587-1598. DOI: 10.1517/13543776.8.12.1587  0.345
1998 Ojima I, Vidal ES. Rhodium-Catalyzed Cyclohydrocarbonylation: Application to the Synthesis of (+)-Prosopinine and (−)-Deoxoprosophylline† Journal of Organic Chemistry. 63: 7999-8003. DOI: 10.1021/Jo9815608  0.309
1998 Ojima I, Lin S, Chakravarty S, Fenoglio I, Park YH, Sun C, Appendino G, Pera P, Veith JM, Bernacki RJ. Syntheses and Structure−Activity Relationships of Novel Nor-seco Taxoids The Journal of Organic Chemistry. 63: 1637-1645. DOI: 10.1021/Jo971953R  0.346
1998 Ojima I, Lin S. Efficient Asymmetric Syntheses of β-Lactams Bearing a Cyclopropane or an Epoxide Moiety and Their Application to the Syntheses of Novel Isoserines and Taxoids Journal of Organic Chemistry. 63: 224-225. DOI: 10.1021/Jo971908J  0.314
1998 Ojima I, Zhu J, Vidal ES, Kass DF. Silylcarbocyclizations of 1,6-Diynes Journal of the American Chemical Society. 120: 6690-6697. DOI: 10.1021/Ja980907L  0.303
1998 Ojima I, Iula DM, Tzamarioudaki M. Efficient syntheses of functionalized piperidines through extremely regioselective Rh-catalyzed cyclohydrocarbonylation of amido-ω,ω'-dienes Tetrahedron Letters. 39: 4599-4602. DOI: 10.1016/S0040-4039(98)00848-X  0.354
1998 Ojima I, Wang H, Wang T, Ng EW. New approaches to the asymmetric synthesis of dipeptide isosteres via β-Lactam Synthon Method Tetrahedron Letters. 39: 923-926. DOI: 10.1016/S0040-4039(97)10677-3  0.3
1998 Distefano M, Scambia G, Ferlini C, Gaggini C, De Vincenzo R, Riva A, Bombardelli E, Ojima I, Fattorossi A, Benedetti Panici P, Mancuso S. Anti-proliferative activity of a new class of taxanes (14β-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells.Int. J. Cancer,72, 844–850 (1997) International Journal of Cancer. 76: 164-164. DOI: 10.1002/(Sici)1097-0215(19980330)76:1<164::Aid-Ijc25>3.0.Co;2-B  0.33
1997 Ojima I, Slater JC. Synthesis of novel 3'-trifluoromethyl taxoids through effective kinetic resolution of racemic 4-CF3-beta-lactams with baccatins. Chirality. 9: 487-94. PMID 9329178 DOI: 10.1002/(Sici)1520-636X(1997)9:5/6<487::Aid-Chir15>3.0.Co;2-K  0.319
1997 Distefano M, Scambia G, Ferlini C, Gaggini C, De Vincenzo R, Riva A, Bombardelli E, Ojima I, Fattorossi A, Panici PB, Mancuso S. Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells. International Journal of Cancer. 72: 844-50. PMID 9311603 DOI: 10.1002/(Sici)1097-0215(19970904)72:5<844::Aid-Ijc22>3.0.Co;2-7  0.34
1997 Ojima I, Kuduk SD, Pera P, Veith JM, Bernacki RJ. Synthesis and structure-activity relationships of nonaromatic taxoids: effects of alkyl and alkenyl ester groups on cytotoxicity. Journal of Medicinal Chemistry. 40: 279-85. PMID 9022794 DOI: 10.1021/Jm9606711  0.318
1997 Ojima I, Slater JC, Kuduk SD, Takeuchi CS, Gimi RH, Sun CM, Park YH, Pera P, Veith JM, Bernacki RJ. Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III. Journal of Medicinal Chemistry. 40: 267-78. PMID 9022793 DOI: 10.1021/Jm960563E  0.354
1997 Ojima I, Slater JC, Pera P, Veith JM, Abouabdellah A, Bégué JP, Bernacki RJ. Synthesis and biological activity of novel 3'-trifluoromethyl taxoids Bioorganic and Medicinal Chemistry Letters. 7: 133-138. DOI: 10.1016/S0960-894X(96)00595-1  0.389
1996 Ojima I, Slater JC, Michaud E, Kuduk SD, Bounaud PY, Vrignaud P, Bissery MC, Veith JM, Pera P, Bernacki RJ. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. Journal of Medicinal Chemistry. 39: 3889-96. PMID 8831755 DOI: 10.1021/Jm9604080  0.363
1996 Ojima I, Machnik D, Donovan RJ, Mneimne O. Silylcyclocarbonylation (SiCCa) of alkynylamines catalyzed by rhodium complexes Inorganica Chimica Acta. 251: 299-307. DOI: 10.1016/S0020-1693(97)82717-X  0.324
1996 Ojima I, McCullagh JV, Shay WR. New cascade silylcarbocyclization (SiCaC) of enediynes Journal of Organometallic Chemistry. 521: 421-423. DOI: 10.1016/0022-328X(96)06359-0  0.301
1995 Sharma A, Straubinger RM, Ojima I, Bernacki RJ. Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice Journal of Pharmaceutical Sciences. 84: 1400-1404. PMID 8748320 DOI: 10.1002/Jps.2600841204  0.326
1995 Ojima I, Tzamarioudaki M, Eguchi M. New and Efficient Route to Pipecolic Acid Derivatives by Means of Rh-Catalyzed Intramolecular Cyclohydrocarbonylation Journal of Organic Chemistry. 60: 7078-7079. DOI: 10.1021/Jo00127A002  0.319
1995 Ojima I, Vidal E, Tzamarioudaki M, Matsuda I. Extremely Regioselective Intramolecular Silylformylation of Alkynes Journal of the American Chemical Society. 117: 6797-6798. DOI: 10.1021/Ja00130A027  0.325
1995 Ojima I, Ng EW, Sun CM. Novel route to hydroxy(keto)ethylene dipeptide isosteres through the reaction of N-tBOC-β-lactams with enolates Tetrahedron Letters. 36: 4547-4550. DOI: 10.1016/0040-4039(95)00825-W  0.345
1994 Ojima I, Duclos O, Zucco M, Bissery MC, Combeau C, Vrignaud P, Riou JF, Lavelle F. Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3' and/or C-2 of taxotere (docetaxel). Journal of Medicinal Chemistry. 37: 2602-8. PMID 7914541 DOI: 10.1021/Jm00042A013  0.333
1994 Ojima I, Fenoglio I, Park YH, Sun C, Appendino G, Pera P, Bernacki RJ. Synthesis and Structure-Activity Relationships of Novel Nor-Seco Analogs of Taxol and Taxotere Journal of Organic Chemistry. 59: 515-517. DOI: 10.1021/Jo00082A003  0.37
1994 Ojima I, Fenoglio I, Park YH, Pera P, Bernacki RJ. Synthesis and biological activity of 14-hydroxydocetaxel Bioorganic & Medicinal Chemistry Letters. 4: 1571-1576. DOI: 10.1016/S0960-894X(01)80568-0  0.335
1994 Ojima I, Duclos O, Kuduk SD, Sun CM, Slater JC, Lavelle F, Veith JM, Bernacki RJ. Synthesis and biological activity of 3′-alkyl- and 3′-alkenyl-3′-dephenyldocetaxels Bioorganic and Medicinal Chemistry Letters. 4: 2631-2634. DOI: 10.1016/S0960-894X(01)80298-5  0.369
1993 Ojima I, Sun CM, Zucco M, Park YH, Duclos O, Kuduk S. A highly efficient route to taxotere by the β-Lactam Synthon Method Tetrahedron Letters. 34: 4149-4152. DOI: 10.1016/S0040-4039(00)60514-2  0.344
1993 Ojima I, Donovan RJ, Eguchi M, Shay WR, Ingallina P, Korda A, Zeng Q. Silylformylation catalyzed by Rh and Rh-Co mixed metal complexes and its application to the synthesis of pyrrolizidine alkaloids Tetrahedron. 49: 5431-5444. DOI: 10.1016/S0040-4020(01)87260-4  0.321
1993 Zhang Z, Ojima I. Syntheses of nitrogen heterocycles by means of amine-directed carbonylation and hydrocarbonylation Journal of Organometallic Chemistry. 454: 281-289. DOI: 10.1016/0022-328X(93)83252-Q  0.308
1992 Ojima I, Pei Y. Novel rearrangements of chiral 3-oxazolidinylazetidin-2-ones Tetrahedron Letters. 33: 887-890. DOI: 10.1016/S0040-4039(00)91567-3  0.343
1992 Ojima I, Habus I, Zhao M, Zucco M, Park YH, Sun CM, Brigaud T. New and efficient approaches to the semisynthesis of taxol and its C-13 side chain analogs by means of β-lactam synthon method Tetrahedron. 48: 6985-7012. DOI: 10.1016/S0040-4020(01)91210-4  0.323
1992 Ojima I, Hoon Park Y, Ming Sun C, Brigaud T, Zhao M. New and efficient routes to norstatine and its analogs with high enantiomeric purity by β-Lactam Synthon Method Tetrahedron Letters. 33: 5737-5740. DOI: 10.1016/0040-4039(92)89019-9  0.305
1991 Ojima I, Korda A, Shay WR. New synthesis of nitrogen heterocycles through amide-directed hydrocarbonylation of alkenamides catalyzed by rhodium complexes Journal of Organic Chemistry. 56: 2024-2030. DOI: 10.1021/Jo00006A013  0.306
1991 Ojima I, Habus I, Zhao M, Georg GI, Jayasinghe LR. Efficient and practical asymmetric synthesis of the taxol C-13 side chain, N-benzoyl-(2R,3S)-3-phenylisoserine, and its analogues via chiral 3-hydroxy-4-aryl-β-lactams through chiral ester enolate-imine cyclocondensation Journal of Organic Chemistry. 56: 1681-1683. DOI: 10.1021/Jo00005A003  0.316
1991 Ojima I. Design and synthesis of novel trifluoromethyl-containing peptides and their use as enzyme inhibitors Journal of Fluorine Chemistry. 54: 187. DOI: 10.1016/S0022-1139(00)83697-0  0.3
1991 Ojima I, Zhang Z. Amide-directed hydrocarbonylation of N-alkenylamides and α-alkenyllactams Journal of Organometallic Chemistry. 417: 253-276. DOI: 10.1016/0022-328X(91)80177-L  0.33
1990 Ojima I. Chapter IV.1 New Carbonylations by Means of Transition Metal Catalysts Studies in Surface Science and Catalysis. 54: 301-321. DOI: 10.1016/S0167-2991(08)60046-4  0.31
1990 Ojima I, Pei Y. Asymmetric synthesis with chiral β-lactams. Highly stereoselective alkylation and aldol reaction of a chiral 3-amino-4-styryl-β-lactam. Tetrahedron Letters. 31: 977-980. DOI: 10.1016/S0040-4039(00)94407-1  0.312
1989 Ojima I, Korda A. New routes to nitrogen heterocycles through intramolecular amidocarbonylation of alkenamides catalyzed by rhodium complexes Tetrahedron Letters. 30: 6283-6286. DOI: 10.1016/S0040-4039(01)93873-0  0.343
1987 Brandstadter SM, Ojima I, Herai K. Reactions of ketene silyl acetals with imine-complexes of titanium tetrachloride. New and convenient routes to 5,6-dihydro-2-pyridones and 5-amino-2-alkenoates Tetrahedron Letters. 28: 613-616. DOI: 10.1016/S0040-4039(00)95794-0  0.331
1985 Ojima I, Yamato T, Nakahashi K. Synthesis of novel chiral bisazetidines by the hydroalane reduction of bis-beta-lactams Tetrahedron Letters. 26: 2035-2038. DOI: 10.1016/S0040-4039(00)94772-5  0.307
1984 Ojima I. Homogeneous asymmetric catalysis by means of chiral rhodium complexes Pure and Applied Chemistry. 56: 99-110. DOI: 10.1351/Pac198456010099  0.319
1984 Fuchikami T, Ojima I. Transition-metal complex catalyzed polyfluoroalkylation. II. Novel and convenient route to 3-polyfluoroalkylprop-1-enes through the reaction of polyfluoroalkyl halides with allylsilanes Tetrahedron Letters. 25: 307-308. DOI: 10.1016/S0040-4039(00)99869-1  0.308
1984 Ojima I, Fuchikami T, Yatabe M. The reactions of hydrosilanes with trifluoropropene and pentafluorostyrene catalyzed by ruthenium, rhodium and palladium complexes Journal of Organometallic Chemistry. 260: 335-346. DOI: 10.1016/S0022-328X(00)99483-X  0.306
1983 Hirai K, Ojima I. Coupling reactions of vinylketene silyl acetals promoted by titanium tetrachloride Tetrahedron Letters. 24: 785-788. DOI: 10.1016/S0040-4039(00)81527-0  0.303
1983 Fuchikami T, Ojima I. Direct perfluoroalkylation of functionalized benzenes with perfluoroalkyl halides and copper bronze Journal of Fluorine Chemistry. 22: 541-556. DOI: 10.1016/S0022-1139(00)81229-4  0.309
1982 OJIMA I, HATANAKA N. Journal of Synthetic Organic Chemistry, Japan. 40: 209-217. DOI: 10.5059/Yukigoseikyokaishi.40.209  0.305
1982 Fuchikami T, Ojima I. New and direct route to 5-trifluoromethyl-5,6-dihydrouracils by means of palladium complex catalyzed “ureidocarbonylation” of 2-bromo-3,3,3-trifluoropropene Tetrahedron Letters. 23: 4099-4100. DOI: 10.1016/S0040-4039(00)88357-4  0.323
1982 Hatanaka N, Abe R, Ojima I. β‐LACTAM AS SYNTHETIC INTERMEDIATE: SYNTHESIS OF LEUCINE‐ENKEPHALIN Cheminform. 13. DOI: 10.1002/Chin.198209322  0.314
1981 Ojima I, Inaba S, Nagai M. Convenient Synthesis of β-Lactams by the Reaction of Ketene Silyl Acetals with Schiff Bases Promoted by Titanium(IV) Chloride Synthesis. 1981: 545-547. DOI: 10.1055/S-1981-29520  0.317
1981 Fuchikami T, Ojima I. Reaction of (bromodifluoromethyl)phenyldimethylsilane with organometallic reagents Journal of Organometallic Chemistry. 212: 145-153. DOI: 10.1016/S0022-328X(00)81910-5  0.314
1980 Ojima I, Yoda N. N-carbamoyl-4-diphenylphosphino-2-diphenylphosphinomethylpyrrolidines(CAPP). Efficient new chiral ligands for asymmetric hydrogenation Tetrahedron Letters. 21: 1051-1054. DOI: 10.1016/S0040-4039(00)78836-8  0.311
1980 Ojima I, Inaba S. Asymmetric synthesis of β-lactams. II. Highly effective asymmetric induction by means of “titanium template” Tetrahedron Letters. 21: 2081-2084. DOI: 10.1016/S0040-4039(00)71492-4  0.322
1980 Ojima I, Inaba S. Asymmetric synthesis of β-lactams. I. The reaction of dimethylketene silyl acetal with (S)-alkylidene(1-arylethyl)amines promoted by titanium tetrachloride Tetrahedron Letters. 21: 2077-2080. DOI: 10.1016/S0040-4039(00)71491-2  0.315
1980 Ojima I, Suzuki T. Asymmetric synthesis of dipeptides by means of homogeneous hydrogenation catalyzed by chiral rhodium complexes Tetrahedron Letters. 21: 1239-1242. DOI: 10.1016/S0040-4039(00)71381-5  0.3
1980 Ojima I, Kogure T. The asymmetric hydrogenation of α-keto esters catalyzed by rhodium(I) complexes with chiral diphosphine ligands. On the catalytic cycles and the mechanism of asymmetric induction Journal of Organometallic Chemistry. 195: 239-248. DOI: 10.1016/S0022-328X(00)90008-1  0.318
1980 Ojima I, Suga S, Abe R. A novel route to dipeptide and its derivative by means of the palladium catalyzed facile cleavage of 1-(1-methoxycarbonyl)alkyl-3-substituted-4-arylazetidin-2-ones Tetrahedron Letters. 21: 3907-3910. DOI: 10.1016/0040-4039(80)80213-9  0.342
1979 OJIMA I, FUCHIKAMI T. Journal of Synthetic Organic Chemistry, Japan. 37: 739-754. DOI: 10.5059/Yukigoseikyokaishi.37.739  0.318
1979 Inaba S, Ojima I, Yoshida K, Nagai M. Reactions of silyl enol ethers and ketene silyl ketals with isocyanates Journal of Organometallic Chemistry. 164: 123-134. DOI: 10.1016/S0022-328X(00)86696-6  0.328
1979 Inaba S, Ojima I. Reaction of trimethylsilyl cyanide with isocyanates and carbodiimides Journal of Organometallic Chemistry. 169: 171-184. DOI: 10.1016/S0022-328X(00)81156-0  0.326
1978 OJIMA I, INABA S. Journal of Synthetic Organic Chemistry, Japan. 36: 610-615. DOI: 10.5059/Yukigoseikyokaishi.36.610  0.336
1978 Ojima I, Kogure T, Achiwa K. EFFECTIVE ASYMMETRIC HYDROGENATION OF ITACONIC ACID CATALYZED BY NEUTRAL AND CATIONIC RHODIUM(I) COMPLEXES WITH CHIRAL PYRROLIDINODIPHOSPHINE LIGAND Chemistry Letters. 7: 567-568. DOI: 10.1246/Cl.1978.567  0.303
1978 Ojima I, Kumagai M. Regioselective hydrosilylation of 1,3-dienes catalyzed by phosphine complexes of palladium and rhodium Journal of Organometallic Chemistry. 157: 359-372. DOI: 10.1016/S0022-328X(00)91720-0  0.336
1978 ACHIWA K, KOGURE T, OJIMA I. ChemInform Abstract: ASYMMETRIC REACTIONS CATALYZED BY CHIRAL METAL COMPLEXES. VIII. HIGHLY EFFECTIVE CATALYTIC ASYMMETRIC SYNTHESIS OF R-(-)-PANTOLACTONE Chemischer Informationsdienst. 9. DOI: 10.1002/Chin.197840196  0.311
1977 Ojima I, Kogure T, Achiwa K. Effective homogeneous hydrogenation of α-keto esters catalysed by neutral rhodium(I) complexes with phosphine ligands and application to the asymmetric synthesis of lactates Journal of the Chemical Society, Chemical Communications. 428-430. DOI: 10.1039/C39770000428  0.301
1977 Ojima I, Kogure T, Kumagai M. Reduction of carbonyl compounds via hydrosilylation. 3. Asymmetric reduction of keto esters via hydrosilylation catalyzed by a rhodium complex with chiral phosphine ligands The Journal of Organic Chemistry. 42: 1671-1679. DOI: 10.1021/Jo00430A001  0.322
1977 Ojima I, Kumagai M, Miyazawa Y. 3-TMS-cyclopentene-1 a new reagent for the synthesis of cyclopentene derivatives Tetrahedron Letters. 18: 1385-1388. DOI: 10.1016/S0040-4039(01)93050-3  0.315
1977 Inaba S, Ojima I. Novel and convenient route to substituted succinates. The dimerization of ketene silyl acetals promoted by titanium tetrachloride Tetrahedron Letters. 18: 2009-2012. DOI: 10.1016/S0040-4039(01)83666-2  0.324
1977 Ojima I, Inaba S, Yoshida K. New and effective route to β-lactams. The reaction of ketene silyl acetals with schiff bases promoted by titanium tetrachloride Tetrahedron Letters. 18: 3643-3646. DOI: 10.1016/S0040-4039(01)83315-3  0.303
1977 Ojima I. Stereochemistry of the regiospecific hydrosilylation of isoprene catalyzed by a phosphine-palladium complex Journal of Organometallic Chemistry. 134: C1-C5. DOI: 10.1016/S0022-328X(00)93621-0  0.329
1977 Ojima I, Inaba S. Reduction of isocyanates and carbodiimides via hydrosilylation Journal of Organometallic Chemistry. 140: 97-111. DOI: 10.1016/S0022-328X(00)84400-9  0.3
1977 Ojima I, Yamamoto K, Kumada M. Asymmetric Hydrosilylation by Means of Homogeneous Catalysts with Chiral Ligands Cheminform. 9: 185-228. DOI: 10.1007/978-94-010-1199-0_3  0.324
1977 Ojima I, Yoshida K, Inaba S. ASYMMETRIC CROSS ALDOL SYNTHESIS. ASYMMETRIC ADDITION OF SILYL ENOL ETHER AND KETENE SILYL ACETAL TO α-KETO ESTERS Chemistry Letters. 6: 429-432. DOI: 10.1002/Chin.197805092  0.311
1977 Ojima I, Kogure T, Achiwa K. EFFECTIVE HOMOGENEOUS HYDROGENATION OF α‐KETO ESTERS CATALYZED BY NEUTRAL RHODIUM(I) COMPLEXES WITH PHOSPHINE LIGANDS AND APPLICATION TO THE ASYMMETRIC SYNTHESIS OF LACTATES Cheminform. 8. DOI: 10.1002/Chin.197746114  0.304
1976 Ojima I, Miyazawa Y, Kumagai M. Asymmetric addition of allyltrimethylsilane to (–)-menthyl pyruvate and phenylglyoxylate Journal of the Chemical Society, Chemical Communications. 927-928. DOI: 10.1039/C39760000927  0.3
1975 OJIMA I, NIHONYANAGI M, KOGURE T, KUMAGAI M, HORIUCI S, NAKATSUGAWA K, NAGAI Y. ChemInform Abstract: REDUCTION OF CARBONYL COMPOUNDS VIA HYDROSILYLATION PART 1, HYDROSILYLATION OF CARBONYL COMPOUNDS CATALYZED BY TRIS(TRIPHENYLPHOSPHINE)CHLORORHODIUM Chemischer Informationsdienst. 6: no-no. DOI: 10.1002/Chin.197551147  0.32
1974 Ojima I, Nagai Y. ASYMMETRIC REDUCTION OF KETONES VIA HYDROSILYLATION CATALYZED BY A RHODIUM(I) COMPLEX WITH CHIRAL PHOSPHINE LIGANDS. II. ON THE MECHANISM OF THE INDUCTION OF ASYMMETRY Chemistry Letters. 3: 223-228. DOI: 10.1246/Cl.1974.223  0.31
1974 Ojima I, Inaba S, Nagai Y. Reaction of trimethylsilyl cyanide with isocyanates Journal of the Chemical Society, Chemical Communications. 826-827. DOI: 10.1039/C39740000826  0.317
1974 Ojima I, Kumagai M, Nagai Y. The stereochemistry of the addition of hydrosilanes to alkyl acetylenes catalyzed by tris(triphenylphosphine)-chlororhodium Journal of Organometallic Chemistry. 66: C14-C16. DOI: 10.1016/S0022-328X(00)93873-7  0.33
1973 Ojima I, Inaba S, Nagai Y. A novel route to formamides and their derivatives. Reduction of isocyanates via hydrosilylation catalyzed by palladium Tetrahedron Letters. 14: 4363-4366. DOI: 10.1016/S0040-4039(01)87223-3  0.341
1973 Ojima I, Inaba S, Nagai Y. A novel route to 2-carbamoylcycloalkanones by the addition reaction of silyl enol ethers to isocyanates Tetrahedron Letters. 14: 4271-4272. DOI: 10.1016/S0040-4039(01)87167-7  0.333
1973 Ojima I, Nagai Y. Reactions of triethylsilyl thiophenoxide with ketones having an electron-with-drawing group on the α-carbon Journal of Organometallic Chemistry. 57: C42-C44. DOI: 10.1016/S0022-328X(00)86579-1  0.327
1973 Ojima I, Akiba K, Inamoto N. Reactions of Diphenylphosphinothioyl Isothiocyanate and Related Compounds with Some Nucleophiles and Carbodiimides Bulletin of the Chemical Society of Japan. 46: 2559-2562. DOI: 10.1002/Chin.197344366  0.304
1972 Kondo K, Ojima I. Reactions of carbenes bearing sulphide linkages at the δ-position Journal of the Chemical Society, Chemical Communications. 860-861. DOI: 10.1039/C39720000860  0.338
1972 Kondo K, Negishi A, Ojima I. Acid-catalyzed ring opening reactions of episulfoxides Journal of the American Chemical Society. 94: 5786-5793. DOI: 10.1021/Ja00771A042  0.309
Low-probability matches (unlikely to be authored by this person)
2000 Kirikae T, Ojima I, Fuero-Oderda C, Lin S, Kirikae F, Hashimoto M, Nakano M. Structural significance of the acyl group at the C-10 position and the A ring of the taxane core of paclitaxel for inducing nitric oxide and tumor necrosis factor production by murine macrophages Febs Letters. 478: 221-226. PMID 10930572 DOI: 10.1016/S0014-5793(00)01858-5  0.3
1992 Ojima I, Donovan RJ, Shay WR. Silylcarbocyclization reactions catalyzed by rhodium and rhodium-cobalt complexes Journal of the American Chemical Society. 114: 6580-6582. DOI: 10.1021/Ja00042A061  0.299
1987 Ojima I. New approaches to the synthesis of organofluorine compounds by means of homogeneous catalysis Journal of Fluorine Chemistry. 35: 31. DOI: 10.1016/0022-1139(87)95023-8  0.299
1998 Hayashi Y, Katada J, Harada T, Tachiki A, Iijima K, Takiguchi Y, Muramatsu M, Miyazaki H, Asari T, Okazaki T, Sato Y, Yasuda E, Yano M, Uno I, Ojima I. GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure. Journal of Medicinal Chemistry. 41: 2345-60. PMID 9632368 DOI: 10.1021/Jm980126V  0.299
2008 Ojima I. Modern molecular approaches to drug design and discovery. Accounts of Chemical Research. 41: 2-3. PMID 18193819 DOI: 10.1021/Ar700158C  0.298
1994 Ojima I, Fracchiolla DA, Donovan RJ, Banerji P. Silylcarbobicyclization of 1,6-Diynes: A Novel Catalytic Route to Bicyclo[3.3.0]octenones Journal of Organic Chemistry. 59: 7594-7595. DOI: 10.1021/Jo00104A012  0.298
2000 Lin S, Fang K, Hashimoto M, Nakanishi K, Ojima I. Design and synthesis of a novel photoaffinity taxoid as a potential probe for the study of paclitaxel-microtubules interactions Tetrahedron Letters. 41: 4287-4290. DOI: 10.1016/S0040-4039(00)00627-4  0.298
1998 Ojima I, Wang T, Delaloge F. Extremely stereoselective alkylation of 3-siloxy-β-lactams and its applications to the asymmetric syntheses of novel 2-alkylisoserines, their dipeptides, and taxoids Tetrahedron Letters. 39: 3663-3666. DOI: 10.1016/S0040-4039(98)00643-1  0.297
2016 Mohelnikova-Duchonova B, Kocik M, Duchonova B, Brynychova V, Oliverius M, Hlavsa J, Honsova E, Mazanec J, Kala Z, Ojima I, Hughes DJ, Doherty JE, Murray HA, Crockard MA, Lemstrova R, et al. Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216. The Pharmacogenomics Journal. PMID 27573236 DOI: 10.1038/Tpj.2016.55  0.297
2014 Moriwaki H, Resch D, Li H, Ojima I, Takeda R, Aceña JL, Soloshonok VA. Synthesis and stereochemical assignments of diastereomeric Ni(II) complexes of glycine Schiff base with (R)-2-(N-{2-[N-alkyl-N-(1-phenylethyl)amino]acetyl}amino)benzophenone; a case of configurationally stable stereogenic nitrogen. Beilstein Journal of Organic Chemistry. 10: 442-8. PMID 24605164 DOI: 10.3762/Bjoc.10.41  0.297
1996 Ojima I, Kass DF, Zhu J. New and Efficient Catalytic Route to Bicyclo[3.3.0]octa-1,5-dien-3-ones Organometallics. 15: 5191-5195. DOI: 10.1021/Om960471N  0.297
1973 Ojima I, Kondo K. Intramolecular Participation of Sulfide Linkage in the Reactivity of Carbene and Diazoalkanes. I. Alkylcarbenes and Diazoalkanes Bearing Alkylthio, Arylthio, and Allylthio Groups ona-Carbon Bulletin of the Chemical Society of Japan. 46: 1539-1545. DOI: 10.1246/Bcsj.46.1539  0.296
1992 Ojima I, Kato K, Jameison FA, Conway J, Nakahashi K, Hagiwara M, Miyamae T, Radunz HE. New potent enkephalin analogs containing trifluoromethylamino acid residues Bioorganic & Medicinal Chemistry Letters. 2: 219-222. DOI: 10.1016/S0960-894X(01)81068-4  0.296
2015 Knudson SE, Awasthi D, Kumar K, Carreau A, Goullieux L, Lagrange S, Vermet H, Ojima I, Slayden RA. Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model. The Journal of Antimicrobial Chemotherapy. PMID 26245639 DOI: 10.1093/Jac/Dkv226  0.296
1972 Kondo K, Ojima I. CYCLOADDITIONS OF DIAZOALKMTES TO VINYL AND ALLYL SULFIDE SYSTEMS Chemistry Letters. 1: 771-774. DOI: 10.1246/Cl.1972.771  0.295
1984 Fuchikami T, Ojima I. Transition-metal complex catalyzed polyfluoroalkylation. I. Facile addition of polyfluoroalkyl halides to carbon-carbon multiple bonds Tetrahedron Letters. 25: 303-306. DOI: 10.1016/S0040-4039(00)99868-X  0.294
1974 Ojima I, Kogure T, Nagai Y. Asymmetric reduction of α-keto esters via hydrosilylation catalyzed by a rhodium(I) complex with chiral phosphin ligands Tetrahedron Letters. 15: 1889-1892. DOI: 10.1016/S0040-4039(01)82586-7  0.294
1985 Ojima I, Hirai K, Fujita M, Fuchikami T. New synthetic route to N-acyl-α-amino acids via amidocarbonylation by means of homogeneous binary catalyst systems Journal of Organometallic Chemistry. 279: 203-214. DOI: 10.1016/0022-328X(85)87018-2  0.293
1983 KOGURE T, OJIMA I. ChemInform Abstract: REDUCTION OF CARBONYL COMPOUNDS VIA HYDROSILYLATION. V. SYNTHESIS OF OPTICALLY ACTIVE ALLYLIC ALCOHOLS VIA REGIOSELECTIVE ASYMMETRIC HYDROSILYLATION Chemischer Informationsdienst. 14. DOI: 10.1002/Chin.198301128  0.293
1975 Ojima I, Inaba S, Nagai Y. Reaction of trimethylsilyl cyanide with carbodiimides Journal of Organometallic Chemistry. 99: C5-C7. DOI: 10.1016/S0022-328X(00)86374-3  0.292
2004 Ojima I. Use of fluorine in the medicinal chemistry and chemical biology of bioactive compounds--a case study on fluorinated taxane anticancer agents. Chembiochem : a European Journal of Chemical Biology. 5: 628-35. PMID 15122634 DOI: 10.1002/Cbic.200300844  0.292
1986 Ojima I. Homogeneous mixed-metal catalyst systems: new and effective routes to N-acyl-α-amino acids via carbonylations Journal of Molecular Catalysis. 37: 25-44. DOI: 10.1016/0304-5102(86)85135-5  0.292
1981 Hatanaka N, Abe R, Ojima I. β-LACTAM AS SYNTHETIC INTERMEDIATE: SYNTHESIS OF LEUCINE-ENKEPHALIN Chemistry Letters. 10: 1297-1298. DOI: 10.1246/Cl.1981.1297  0.291
2017 Alford VM, Kamath A, Ren X, Kumar K, Gan Q, Awwa M, Tong M, Seeliger MA, Cao J, Ojima I, Sampson NS. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions. Acs Chemical Biology. PMID 28945333 DOI: 10.1021/Acschembio.7B00758  0.289
1994 Ojima I, Tzamarioudaki M, Tsai C. Extremely Chemoselective Silylformylation and Silylcarbocyclization of Alkynals Journal of the American Chemical Society. 116: 3643-3644. DOI: 10.1021/Ja00087A078  0.289
1995 Ojima I, Duclos O, Dormán G, Simonot B, Prestwich GD, Rao S, Lerro KA, Horwitz SB. A new paclitaxel photoaffinity analog with a 3-(4-benzoylphenyl)propanoyl probe for characterization of drug-binding sites on tubulin and P-glycoprotein. Journal of Medicinal Chemistry. 38: 3891-4. PMID 7562921 DOI: 10.1021/Jm00020A001  0.288
1997 Ojima I, Delaloge F. Asymmetric synthesis of building-blocks for peptides and peptidomimetics by means of the β-lactam synthon method Chem. Soc. Rev.. 26: 377-386. DOI: 10.1039/Cs9972600377  0.288
1975 Ojima I, Kogure T, Nagai Y. SELECTIVE ASYMMETRIC REDUCTION OF α,β-UNSATURATED KETONES VIA HYDROSILYLATION CATALYZED BY RHODIUM(I) COMPLEXES WITH CHIRAL PHOSPHINE LIGANDS Chemistry Letters. 4: 985-988. DOI: 10.1002/Chin.197606105  0.288
1975 OJIMA I, INABA S, NAGAI Y. ChemInform Abstract: A FACILE SYNTHESIS OF N-(P-TOLUENESULFONYL)-2-OXOALKANECARBONAMIDES BY THE REACTION OF SILYL ENOL ETHERS WITH P-TOLUENESULFONYL ISOCYANATE Chemischer Informationsdienst. 6: no-no. DOI: 10.1002/Chin.197543224  0.287
1978 ACHIWA K, KOGURE T, OJIMA I. ChemInform Abstract: ASYMMETRIC REACTIONS CATALYZED BY TRANSITION METAL COMPLEXES. VI. CATALYTIC ASYMMETRIC SYNTHESES OF R(-)- AND S(+)-PANTOLACTONE Chemischer Informationsdienst. 9. DOI: 10.1002/Chin.197807194  0.286
1981 Hatanaka N, Ojima I. Effective method for the asymmetric synthesis of bis-β-lactams by the cycloaddition of azidoketen to benzylideneamines bearing a chiral β-lactam backbone Journal of the Chemical Society, Chemical Communications. 344-346. DOI: 10.1039/C39810000344  0.286
1973 Ojima I, Kogure T, Nagai Y. ASYMMETRIC REDUCTION OF KETONES VIA HYDROSILYLATION CATALYZED BY A RHODIUM(I) COMPLEX WITH CHIRAL PHOSPHINE LIGANDS Chemistry Letters. 2: 541-544. DOI: 10.1246/Cl.1973.541  0.285
1977 Ojima I, Miyazawa Y, Kumagai M. Asymmetric Addition Of Allyltrimethylsilane To (-)-Menthyl Pyruvate And Phenylglyoxylate Cheminform. 8. DOI: 10.1002/Chin.197712089  0.285
1991 Ojima I, Clos N, Donovan RJ, Ingallina P. Reactions of Co2Rh2(CO)12 with isocyanides and 1-alkynes. Characterization of new isocyanide and 1-alkyne complexes of Co-Rh mixed-metal systems and the structures of [Rh(C.tplbond.N-C6H3Me2-2,6)4][Co(CO)4] and Co2Rh2(CO)7(.mu.-CO)2(.mu.4,.eta.2-HC.tplbond.CBun)(PPh3) Organometallics. 10: 3211-3219. DOI: 10.1021/Om00055A044  0.285
2014 Knudson SE, Awasthi D, Kumar K, Carreau A, Goullieux L, Lagrange S, Vermet H, Ojima I, Slayden RA. A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis. Plos One. 9: e93953. PMID 24736743 DOI: 10.1371/Journal.Pone.0093953  0.285
1984 Fuchikami T, Yamanouchi A, Ojima I. An Effective and Convenient Route to 5-Trifluoromethyl-5,6-dihydrouracils and their Thio Derivatives Synthesis. 1984: 766-768. DOI: 10.1055/S-1984-30964  0.284
1999 Ojima I, Bounaud PY, Ahern DG. New photoaffinity analogs of paclitaxel Bioorganic and Medicinal Chemistry Letters. 9: 1189-1194. PMID 10328311 DOI: 10.1016/S0960-894X(99)00161-4  0.283
1979 Ojima I, Kogure T. 31P NMR STUDIES ON THE MECHANISM OF ASYMMETRIC HYDROGENATION CATALYZED BY RHODIUM(I) COMPLEXES WITH CHIRAL PYRROLIDINODIPHOSPHINE LIGAND. EVIDENCE FOR EXTREMELY REGIOSELECTIVE COMPLEXATION OF PROCHIRAL SUBSTRATES Chemistry Letters. 8: 641-644. DOI: 10.1246/Cl.1979.641  0.283
2001 Bonafoux D, Ojima I. Novel DMAP-catalyzed skeletal rearrangement of 5-exo-(2-hydroxyethylene)oxasilacyclopentanes Organic Letters. 3: 2333-2335. DOI: 10.1021/Ol016153O  0.283
2003 Ojima I, Fumero-Oderda CL, Kuduk SD, Ma Z, Kirikae F, Kirikae T. Structure-activity relationship study of taxoids for their ability to activate murine macrophages as well as inhibit the growth of macrophage-like cells. Bioorganic & Medicinal Chemistry. 11: 2867-88. PMID 12788358 DOI: 10.1016/S0968-0896(03)00181-0  0.282
2019 Zhou Y, Elmes MW, Sweeney J, Joseph O, Che J, Hsu HC, Li H, Deutsch DG, Ojima I, Kaczocha M, Rizzo RC. Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-based Screening. Biochemistry. PMID 31539229 DOI: 10.1021/Acs.Biochem.9B00625  0.282
1983 Fuchikami T, Ohishi K, Ojima I. Regioselective hydroesterification and hydrocarboxylation of 3,3,3-trifluoropropene and pentafluorostyrene catalyzed by phosphine-palladium complex The Journal of Organic Chemistry. 48: 3803-3807. DOI: 10.1002/Chin.198411142  0.282
1989 Ojima I, Kato K, Nakahashi K, Fuchikami T, Fujita M. New and effective routes to fluoro analogs of aliphatic and aromatic amino acids The Journal of Organic Chemistry. 54: 4511-4522. DOI: 10.1021/Jo00280A014  0.282
1972 Ojima I, Nihonyanagi M, Nagai Y. Rhodium complex catalysed hydrosilylation of carbonyl compounds Journal of the Chemical Society, Chemical Communications. DOI: 10.1039/C3972000938A  0.281
1975 Ojima I, Inaba S, Nagai Y. Reaction Of Trimethylsilyl Cyanide With Isocyanates Cheminform. 6. DOI: 10.1002/Chin.197504258  0.28
1973 Ojima I, Kondo K. Chemical Evidence for the Existence of pπ-dπ Interaction between the Unsaturated Bond and the Sulfur Atom in Allyl and Vinyl Sulfide Systems Bulletin of the Chemical Society of Japan. 46: 2571-2574. DOI: 10.1246/Bcsj.46.2571  0.28
1994 Ojima I, Tsai C, Zhang Z. Catalytic asymmetric synthesis of peptides on polymer support Tetrahedron Letters. 35: 5785-5788. DOI: 10.1016/S0040-4039(00)78184-6  0.28
1991 Ojima I, Ingallina P, Donovan RJ, Clos N. Silylformylation of 1-hexyne catalyzed by rhodium-cobalt mixed-metal carbonyl clusters Organometallics. 10: 38-41. DOI: 10.1021/Om00047A021  0.28
1969 Ojima I, Akiba K, Inamoto N. Reactions of Diarylphosphines, Their Oxides and Sulfides with Isothiocyanates and Thiocyanic Acid Bulletin of the Chemical Society of Japan. 42: 2975-2981. DOI: 10.1246/Bcsj.42.2975  0.28
1988 Ojima I, Chen HC, Qiu X. New approaches to the asymmetric synthesis of non-proteinogenic α-amino acids and dipeptides through chiral β-lactam intermediates Tetrahedron. 44: 5307-5318. DOI: 10.1016/S0040-4020(01)86038-5  0.28
1996 Ojima I, Kuduk SD, Slater JC, Gimi RH, Sun CM. Syntheses of new fluorine-containing taxoids by means of β-Lactam Synthon Method Tetrahedron. 52: 209-224. DOI: 10.1016/0040-4020(95)00865-6  0.279
1979 Ojima I, Kogure T, Terasaki T, Achiwa K. Effective biomimetic route to D-(+)-pantothenate using asymmetric hydrogenation catalyzed by a chiral rhodium complex in the key step Cheminform. 10. DOI: 10.1002/Chin.197906319  0.279
1978 Ojima I, Kogure T, Terasaki T, Achiwa K. Effective biomimetic route to D-(+)-pantothenate using asymmetric hydrogenation catalyzed by a chiral rhodium complex in the key step The Journal of Organic Chemistry. 43: 3444-3446. DOI: 10.1021/Jo00412A003  0.279
2001 Gruol DJ, Bernd J, Phippard AE, Ojima I, Bernacki RJ. The use of a novel taxane-based P-glycoprotein inhibitor to identify mutations that alter the interaction of the protein with paclitaxel Molecular Pharmacology. 60: 104-113. PMID 11408605 DOI: 10.1124/Mol.60.1.104  0.279
1978 Ojima I, Kumagai M. CHEMOSELECTIVE REACTIONS OF ALLYLSILANES WITH 1,1-DIMETHOXYBUTAN-3-ONE AND 1,1-DIMETHOXYPROPAN-2-ONE Chemistry Letters. 7: 575-578. DOI: 10.1002/Chin.197846170  0.278
1982 Ojima I, Yatabe M, Fuchikami T. Diels-Alder reactions of (trifluoromethyl)ethene and (trifluoromethyl)styrenes with functionalized butadienes The Journal of Organic Chemistry. 47: 2051-2055. DOI: 10.1021/Jo00132A015  0.278
1972 Ojima I, Kogure T, Nihonyanagi M, Nagai Y. Reduction of Carbonyl Compounds with Various Hydrosilane-Rhodium(I) Complex Combinations Bulletin of the Chemical Society of Japan. 45: 3506-3506. DOI: 10.1246/Bcsj.45.3506  0.278
2017 Zong Y, Shea C, Maffucci K, Ojima I. Computational Design and Synthesis of Novel Fluoro-Analogs of Combretastatins A-4 and A-1. Journal of Fluorine Chemistry. 203: 193-199. PMID 29311752 DOI: 10.1016/J.Jfluchem.2017.09.007  0.277
1972 OJIMA I, NIHONYANAGI M, NAGAI Y. ChemInform Abstract: DURCH RHODIUM-KOMPLEXE KATALYSIERTE HYDROSILYLIERUNG VON CARBONYL-VERBINDUNGEN Chemischer Informationsdienst. 3: no-no. DOI: 10.1002/Chin.197250301  0.277
1982 Ojima I, Kogure T, Yoda N, Suzuki T, Yatabe M, Tanaka T. Synthesis of chiral dipeptides by means of asymmetric hydrogenation of dehydro dipeptides The Journal of Organic Chemistry. 47: 1329-1334. DOI: 10.1021/Jo00346A033  0.276
1988 Ojima I, Chen HJC, Nakahashi K. Asymmetric synthesis with chiral .beta.-lactams. .alpha.-Substituted aromatic .alpha.-amino acids and their derivatives through highly stereoselective alkylations Journal of the American Chemical Society. 110: 278-281. DOI: 10.1021/Ja00209A044  0.276
1985 Ojima I. Asymmetric Synthesis. Volume 4. The Chiral Carbon Pool and Chiral Sulfur, Nitrogen, Phosphorus, and Silicon Centers Organometallics. 4: 960-960. DOI: 10.1021/Om00124A605  0.276
1980 Ojima I, Kogure T, Yoda N. Asymmetric hydrogenation of prochiral olefins catalyzed by rhodium complexes with chiral pyrrolidinodiphosphines. Crucial factors for the effective asymmetric induction The Journal of Organic Chemistry. 45: 4728-4739. DOI: 10.1021/Jo01311A036  0.276
1995 Ojima I, Dong Q, Chakravarty S, Peerschke E, Hwang SM, Wong AS. Design, synthesis and SAR of RGD peptide hybrids as highly efficient inhibitors of platelet aggregation Bioorganic and Medicinal Chemistry Letters. 5: 1941-1946. DOI: 10.1016/0960-894X(95)00329-R  0.275
1981 Fuchikami T, Yatabe M, Ojima I. A Facile Synthesis oftrans-β-Trifluoromethylstyrene,trans-2,3,4,5,6-Pentafluorostilbene and their Derivatives Synthesis. 1981: 365-366. DOI: 10.1055/S-1981-29449  0.275
1983 Fujita M, Ojima I. Selenium dioxide oxidation of 3-methyl-4,5,6,7-tetrafluoroindoles: an efficient route to tetrafluoro analogs of 3-formyl and 3-acetoxymethylindole systems Tetrahedron Letters. 24: 4573-4576. DOI: 10.1016/S0040-4039(00)85959-6  0.275
1982 Ojima I, Yoda N. Synthesis of chiral tripeptides by asymmetric hydrogenation of dehydrotripeptides. Remarkable effects of N-protecting groups on stereoselectivity and reactivity Tetrahedron Letters. 23: 3913-3916. DOI: 10.1016/S0040-4039(00)87741-2  0.275
1972 Ojima I, Nihonyanagi M, Nagai Y. Stereoselective Reduction of Ketones with Hydrosilane-Rhodium(I) Complex Combinations Bulletin of the Chemical Society of Japan. 45: 3722-3722. DOI: 10.1246/Bcsj.45.3722  0.274
1978 Achiwa K, Kogure T, Ojima I. HIGHLY EFFECTIVE CATALYTIC ASYMMETRIC SYNTHESIS OF R-(−)-PANTOLACTONE Chemistry Letters. 7: 297-298. DOI: 10.1246/Cl.1978.297  0.274
1998 Ojima I, Zhaoyang L, Donovan RJ, Ingallina P. On the mechanism of silylformylation catalyzed by Rh-Co mixed metal complexes Inorganica Chimica Acta. 270: 279-284. DOI: 10.1016/S0020-1693(97)05855-6  0.274
1992 Ojima I, Brandstadter SM, Donovan RJ. Oxidative Dimerization of Lithium-Enolates of Esters Promoted by TitaniumTetrachloride Chemistry Letters. 21: 1591-1594. DOI: 10.1246/Cl.1992.1591  0.273
1976 Ojima I, Kumagai M, Nagai Y. Hydrosilylation of α,β-unsaturated nitriles and esters catalyzed by tris (triphenylphosphine)chlororhodium Journal of Organometallic Chemistry. 111: 43-60. DOI: 10.1016/S0022-328X(00)87057-6  0.273
2016 Zhou Y, McGillick BE, Teng YG, Haranahalli K, Ojima I, Swaminathan S, Rizzo RC. Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity. Bioorganic & Medicinal Chemistry. PMID 27543389 DOI: 10.1016/J.Bmc.2016.07.031  0.273
1973 Ojima I, Nihonyanagi M, Nagai Y. A novel route to silylthioethers Journal of Organometallic Chemistry. 50: C26-C28. DOI: 10.1016/S0022-328X(00)95067-8  0.273
2006 Yoshikai N, Yamanaka M, Ojima I, Morokuma K, Nakamura E. Bimetallic synergism in alkyne silylformylation catalyzed by a cobalt - Rhodium mixed-metal cluster Organometallics. 25: 3867-3875. DOI: 10.1021/Om060478X  0.273
2013 Ojima I. Exploration of fluorine chemistry at the multidisciplinary interface of chemistry and biology. The Journal of Organic Chemistry. 78: 6358-83. PMID 23614876 DOI: 10.1021/Jo400301U  0.272
1972 Kondo K, Ojima I. Intramolecular reactions of α- and β-allylthioalkylcarbenes Journal of the Chemical Society, Chemical Communications. 62-63. DOI: 10.1039/C39720000062  0.272
2021 Wang C, Chen L, Sun Y, Guo W, Taouil AK, Ojima I. Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids. Bioorganic Chemistry. 119: 105578. PMID 34979464 DOI: 10.1016/j.bioorg.2021.105578  0.271
1978 Ojima I, Kogure T. 31P NMR STUDIES ON THE MECHANISM OF ASYMMETRIC HYDROGENATION CATALYZED BY RHODIUM(I) COMPLEXES WITH CHIRAL PYRROLIDINODIPHOSPHINE LIGAND Chemistry Letters. 7: 1145-1148. DOI: 10.1246/Cl.1978.1145  0.271
1987 Ojima I, Qiu X. Asymmetric alkylation of chiral .beta.-lactam ester enolates. A new approach to the synthesis of .alpha.-alkylated .alpha.-amino acids Journal of the American Chemical Society. 109: 6537-6538. DOI: 10.1021/Ja00255A063  0.271
1981 Ojima I, Tanaka T, Kogure T. SYNTHESIS OF CHIRAL DEPSIPEPTIDE BUILDING BLOCK BY THE ASYMMETRIC REDUCTION OFN-(α-KETOACYL)-α-AMINO ESTERS Chemistry Letters. 10: 823-826. DOI: 10.1002/Chin.198149338  0.27
1992 Ojima I, Donovan RJ, Ingallina P, Clos N, Shay WR, Eguchi M, Zeng Q, Korda A. Organometallic chemistry and homogeneous catalysis of Rh and Rh-Co mixed metal carbonyl clusters Journal of Cluster Science. 3: 423-438. DOI: 10.1007/Bf00702749  0.27
2014 Zheng S, Huang JT, Knatko EV, Sharp S, Higgins M, Ojima I, Dinkova-Kostova AT, Honda T. Synthesis of (13) C2 (15) N2 -labeled anti-inflammatory and cytoprotective tricyclic bis(cyanoenone) ([(13) C2 (15) N2 ]-TBE-31) as an internal standard for quantification by stable isotope dilution LC-MS method. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 606-10. PMID 25196444 DOI: 10.1002/Jlcr.3230  0.27
1984 Ojima I, Noriko Yoda T, Yatabe M, Tanaka T, Kogure T. Synthesis of chiral oligopeptides by means of catalytic asymmetric hydrogenation of dehydropeptides Tetrahedron. 40: 1255-1268. DOI: 10.1016/S0040-4020(01)82412-1  0.27
1982 Hatanaka N, Abe R, Ojima I. SYNTHESIS OF OPTICALLY PURE ENKEPHALIN ANALOG, [D-Ala2, Leu5-ol]ENKEPHALIN, USING CHIRAL β-LACTAMS AS SYNTHETIC INTERMEDIATES Chemistry Letters. 11: 445-448. DOI: 10.1002/Chin.198245342  0.269
1996 Ojima I, Chakravarty S, Dong Q. Antithrombotic agents: from RGD to peptide mimetics. Bioorganic & Medicinal Chemistry. 3: 337-60. PMID 8581417 DOI: 10.1016/0968-0896(95)00036-G  0.269
2012 Ojima I, Hirai K. Asymmetric Hydrosilylation and Hydrocarbonylation Asymmetric Synthesis. 103-146. DOI: 10.1002/Chin.198634368  0.269
1982 Hirai K, Takahashi Y, Ojima I. Direct conversion of allylic alcohols into N-acyl-α-amino acids by catalytic amidocarbonylation by means of homogeneous binary systems Tetrahedron Letters. 23: 2491-2494. DOI: 10.1016/S0040-4039(00)87377-3  0.269
1979 Ojima I, Inaba S. A convenient synthesis of 1,3-dimethyl(5h,7h)imidazo(4,5-dpyrimidine-2,4,6-trithione and its unusual character Tetrahedron Letters. 20: 817-820. DOI: 10.1016/S0040-4039(01)86047-0  0.268
1996 Hayashi Y, Sato Y, Katada J, Takiguchi Y, Ojima I, Uno I. Design and synthesis of new antagonist peptides for platelet GPIIb/IIIa receptor as anti-thrombotic agents Bioorganic & Medicinal Chemistry Letters. 6: 1351-1356. DOI: 10.1016/0960-894X(96)00224-7  0.268
1993 Ojima I, Zucco M, Duclos O, Kuduk SD, Sun CM, Park YH. N-acyl-3-hydroxy-β-lactams as key intermediates for taxotere and its analogs Bioorganic & Medicinal Chemistry Letters. 3: 2479-2482. DOI: 10.1016/S0960-894X(01)80982-3  0.268
1999 Glunz PW, He L, Horwitz SB, Chakravarty S, Ojima I, Chou TC, Danishefsky SJ. The synthesis and evaluation of 12,13-benzodesoxyepothilone B: A highly convergent route Tetrahedron Letters. 40: 6895-6898. DOI: 10.1016/S0040-4039(99)01433-1  0.267
2005 Yang CP, Verdier-Pinard P, Wang F, Lippaine-Horvath E, He L, Li D, Höfle G, Ojima I, Orr GA, Horwitz SB. A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence. Molecular Cancer Therapeutics. 4: 987-95. PMID 15956256 DOI: 10.1158/1535-7163.Mct-05-0024  0.267
1974 OJIMA I. Journal of Synthetic Organic Chemistry, Japan. 32: 687-703. DOI: 10.5059/Yukigoseikyokaishi.32.687  0.266
1970 Ojima I, Inamoto N. 1,2-Cycloaddition of phosphinothioyl and sulphonyl isothiocyanates with carbodi-imides Journal of the Chemical Society D: Chemical Communications. 1629-1629. DOI: 10.1039/C29700001629  0.266
1997 Ojima I, Kuduk SD, Chakravarty S, Ourevitch M, Bégué J. A Novel Approach to the Study of Solution Structures and Dynamic Behavior of Paclitaxel and Docetaxel Using Fluorine-Containing Analogs as Probes Journal of the American Chemical Society. 119: 5519-5527. DOI: 10.1021/Ja9633777  0.266
1998 Wu Q, Bounaud PY, Kuduk SD, Yang CP, Ojima I, Horwitz SB, Orr GA. Identification of the domains of photoincorporation of the 3'- and 7-benzophenone analogues of taxol in the carboxyl-terminal half of murine mdr1b P-glycoprotein. Biochemistry. 37: 11272-9. PMID 9698374 DOI: 10.1021/Bi980598B  0.266
1970 EMOTO T, OKAZAKI R, OJIMA I, OCHIAI T, KAWASHIMA T, NAKAYAMA J, NAKAYAMA S, YAMADA K, YOSHIFUJI M. Tables for Syntheses of Organophosphorus Compounds Journal of Synthetic Organic Chemistry, Japan. 28: 143-176. DOI: 10.5059/Yukigoseikyokaishi.28.143  0.265
1982 Ojima I, Kogure T. Reduction of carbonyl compounds via hydrosilylation. 4. Highly regioselective reductions of .alpha.,.beta.-unsaturated carbonyl compounds Organometallics. 1: 1390-1399. DOI: 10.1021/Om00070A024  0.265
1999 Ojima I, Lin S, Wang T. Recent advances in the medicinal chemistry of taxoids with novel β- amino acid side chains Current Medicinal Chemistry. 6: 927-954. PMID 10519906  0.264
1987 Ojima I, Chen HC. Novel and effective routes to optically pure amino acids, dipeptides, and their derivatives viaβ-lactams obtained through asymmetric cycloaddition Journal of the Chemical Society, Chemical Communications. 625-626. DOI: 10.1039/C39870000625  0.264
1989 Ojima I, Clos N, Bastos C. Recent advances in catalytic asymmetric reactions promoted by transition metal complexes Tetrahedron. 45: 6901-6939. DOI: 10.1016/S0040-4020(01)89159-6  0.264
1988 Ojima I, Kwon HB. Remarkable effects of a pentafluorophenyl group on the stereoselective reactions of a chiral iron acyl complex Journal of the American Chemical Society. 110: 5617-5621. DOI: 10.1021/Ja00225A004  0.264
1979 Ojima I, Kogure T, Yoda N. ASYMMETRIC HYDROGENATION OF α-ACYLAMINOCINNAMIC ACID CATALYZED BY CHIRAL RHODIUM COMPLEXES. REMARKABLE EFFECTS OF HYDROGEN PRESSURE ON STEREOSELECTIVITY Chemistry Letters. 8: 495-498. DOI: 10.1246/Cl.1979.495  0.263
1994 OJIMA I, DONG Q, CHAKRAVARTY S. Platelet Aggregation Inhibitory Agents: From RGD to Peptide Mimetics. Journal of Synthetic Organic Chemistry, Japan. 52: 413-425. DOI: 10.5059/Yukigoseikyokaishi.52.413  0.263
2019 Oliverius M, Flasarova D, Mohelnikova-Duchonova B, Ehrlichova M, Hlavac, Kocik M, Strouhal O, Dvorak P, Ojima I, Soucek P. KRAS pathway expression changes in pancreatic cancer models by conventional and experimental taxanes Mutagenesis. 34: 403-411. PMID 31375828 DOI: 10.1093/Mutage/Gez021  0.262
1976 Ojima I, Kogure T, Kumagai M, Horiuchi S, Sato T. Reduction of carbonyl compounds via hydrosilylation Journal of Organometallic Chemistry. 122: 83-97. DOI: 10.1016/S0022-328X(00)86954-5  0.262
1975 Ojima I, Inaba S, Nakatsugawa K, Nagai Y. A NEW ROUTE TO AMINONITRILES VIA CYANOSILYLATION OF SCHIFF BASES AND OXIMES Chemistry Letters. 4: 331-334. DOI: 10.1002/Chin.197545212  0.262
2019 Kim J, Bogdan DM, Elmes MW, Awwa M, Yan S, Che J, Lee G, Deutsch DG, Rizzo RC, Kaczocha M, Ojima I. Incarvillateine produces antinociceptive and motor suppressive effects via adenosine receptor activation. Plos One. 14: e0218619. PMID 31237895 DOI: 10.1371/Journal.Pone.0218619  0.262
2013 Jelínek M, Balušíková K, Kopperová D, Nĕmcová-Fürstová V, Šrámek J, Fidlerová J, Zanardi I, Ojima I, Kovář J. Caspase-2 is involved in cell death induction by taxanes in breast cancer cells. Cancer Cell International. 13: 42. PMID 23672670 DOI: 10.1186/1475-2867-13-42  0.262
1974 Ojima I, Inaba S, Nagai Y. Syntheses of N-silylformamidines by the hydrosilylation of carbodiimides Journal of Organometallic Chemistry. 72: C11-C13. DOI: 10.1016/S0022-328X(00)82030-6  0.262
1983 Yamashita M, Ojima I. Effective route to azetidines from azetidin-2-ones with the use of hydroalanes as specific reducing agents Cheminform. 15: 6339-6342. DOI: 10.1021/Ja00358A040  0.261
1986 OJIMA I. Asymmetric synthesis by means of chiral metal complex catalysts. Journal of Synthetic Organic Chemistry, Japan. 44: 499-512. DOI: 10.1002/Chin.198651362  0.26
1975 Ojima I. Recent Progress In The Catalytic Asymmetric Reductions Using Homogeneous Catalysts With Chiral Ligands Cheminform. 6. DOI: 10.1002/Chin.197511165  0.26
1998 Kirikae T, Ojima I, Ma Z, Kirikae F, Hirai Y, Nakano M. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages. Biochemical and Biophysical Research Communications. 245: 698-704. PMID 9588177 DOI: 10.1006/Bbrc.1998.8409  0.259
1969 Ojima I, Iwamoto T, Onishi T, Inamoto N, Tamaru K. A novel series of transition-metal chelates of diphenylphosphinothioylthiourea anion Journal of the Chemical Society D: Chemical Communications. 1501-1502. DOI: 10.1039/C29690001501  0.259
1975 Ojima I, Inaba S, Nagai Y. ASYMMETRIC SYNTHESES OF α-AMINONITRILES VIA CYANOSILYLATION OF SCHIFF BASES Chemistry Letters. 4: 737-740. DOI: 10.1002/Chin.197601180  0.259
2009 Ojima I. Bioorganic and Medicinal Chemistry of Fluorine. By Jean-Pierre Bégué and Danièle Bonnet-Delpon. Chembiochem. 10: 377-377. DOI: 10.1002/Cbic.200800794  0.256
2015 Jelínek M, Balušíková K, Schmiedlová M, Němcová-Fürstová V, Šrámek J, Stančíková J, Zanardi I, Ojima I, Kovář J. The role of individual caspases in cell death induction by taxanes in breast cancer cells. Cancer Cell International. 15: 8. PMID 25685064 DOI: 10.1186/S12935-015-0155-7  0.255
1988 Ojima I, Zhang Z. Novel amide-directed hydrocarbonylations and double carbonylation of N-allylamides The Journal of Organic Chemistry. 53: 4422-4425. DOI: 10.1021/Jo00253A051  0.255
1994 Ojima I, Park YH, Sun CM, Fenoglio I, Appendino G, Pera P, Bernacki RJ. Structure-activity relationships of new taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III. Journal of Medicinal Chemistry. 37: 1408-10. PMID 8182698 DOI: 10.1021/Jm00036A004  0.255
2003 Ojima I, Kogure T, Yoda Y. Asymmetric Hydrogenation of Ketopantoyl Lactone: D‐(−)‐Pantoyl Lactone Organic Syntheses. 18-18. DOI: 10.1002/0471264180.Os063.03  0.254
1996 Kirikae T, Ojima I, Kirikae F, Ma Z, Kuduk SD, Slater JC, Takeuchi CS, Bounaud PY, Nakano M. Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages. Biochemical and Biophysical Research Communications. 227: 227-35. PMID 8858130 DOI: 10.1006/Bbrc.1996.1494  0.254
2017 Hsu HC, Tong S, Zhou Y, Elmes MW, Yan S, Kaczocha M, Deutsch DG, Rizzo RC, Ojima I, Li H. The antinociceptive agent SBFI-26 binds to anandamide transporters FABP5 and FABP7 at two different sites. Biochemistry. PMID 28632393 DOI: 10.1021/Acs.Biochem.7B00194  0.254
1997 Asari T, Ishikawa S, Sasaki T, Katada J, Hayashi Y, Harada T, Yano M, Yasuda E, Uno I, Ojima I. Development of new non-peptide GPIIb/IIIa antagonists, NSL-95315 and NSL-95317, isosteres of NSL-95300 Bioorganic & Medicinal Chemistry Letters. 7: 2099-2104. DOI: 10.1016/S0960-894X(97)00366-1  0.253
2014 Sanson B, Wang T, Sun J, Wang L, Kaczocha M, Ojima I, Deutsch D, Li H. Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. Acta Crystallographica. Section D, Biological Crystallography. 70: 290-8. PMID 24531463 DOI: 10.1107/S1399004713026795  0.253
1993 Eguchi M, Zeng Q, Korda A, Ojima I. Synthesis of pyrrolizidine alkaloids via rhodium-catalyzed silylformylation and amidocarbonylation Tetrahedron Letters. 34: 915-918. DOI: 10.1016/S0040-4039(00)77453-3  0.252
1973 Ojima I, Kogure T, Nagai Y. A novel method for the reduction of schiff bases using catalytic hydrosilylation Tetrahedron Letters. 14: 2475-2478. DOI: 10.1016/S0040-4039(01)96182-9  0.251
1991 Ojima I, Zhao M, Yamato T, Nakahashi K, Yamashita M, Abe R. Azetidines and bisazetidines. Their synthesis and use as the key intermediates to enantiomerically pure diamines, amino alcohols, and polyamines Journal of Organic Chemistry. 56: 5263-5277. DOI: 10.1021/Jo00018A012  0.25
2011 Chien C-, Shi C, Lin C-, Ojima I. Pd-Catalyzed Intramolecular Asymmetric Allylic Amination Synfacts. 2011: 1339-1339. DOI: 10.1055/S-0031-1289330  0.25
1999 Rao S, He L, Chakravarty S, Ojima I, Orr GA, Horwitz SB. Characterization of the Taxol binding site on the microtubule. Identification of Arg(282) in beta-tubulin as the site of photoincorporation of a 7-benzophenone analogue of Taxol. The Journal of Biological Chemistry. 274: 37990-4. PMID 10608867 DOI: 10.1074/Jbc.274.53.37990  0.25
1973 Kono H, Ojima I, Matsumoto M, Nagai Y. A CONVENIENT ROUTE TO AMINOSILANES USING HYDROSILANE-RHODIUM(I) COMPLEX COMBINATIONS Organic Preparations and Procedures International. 5: 135-139. DOI: 10.1080/00304947309355562  0.249
2014 Singh D, Bhattacharya A, Rai A, Dhaked HP, Awasthi D, Ojima I, Panda D. SB-RA-2001 inhibits bacterial proliferation by targeting FtsZ assembly. Biochemistry. 53: 2979-92. PMID 24749867 DOI: 10.1021/Bi401356Y  0.249
1986 Ojima I, Shimizu N. Extremely stereoselective and stereospecific reductive cleavage of .beta.-lactams. A highly efficient route to labeled homochiral peptides Journal of the American Chemical Society. 108: 3100-3102. DOI: 10.1021/Ja00271A048  0.249
2001 Bonafoux D, Ojima I. Desymmetrization of 4-dimethylsiloxy-1,6-heptadiynes through sequential double silylformylation Organic Letters. 3: 1303-1304. DOI: 10.1021/Ol0156594  0.248
1981 Hatanaka N, Ojima I. β-LACTAM AS SYNTHETIC INTERMEDIATE. A NEW SYNTHETIC APPROACH TO OLIGOPEPTIDES THROUGH NOVEL β-LACTAMS Cheminform. 12. DOI: 10.1002/Chin.198135328  0.248
1997 Harada T, Katada J, Tachiki A, Asari T, Iijima K, Uno I, Ojima I, Hayashi Y. Development of the new potent non-peptide gpIIb/IIIa antagonist NSL-95301 by utilizing combinatorial technique Bioorganic & Medicinal Chemistry Letters. 7: 209-212. DOI: 10.1016/S0960-894X(96)00610-5  0.248
1974 Ojima I, Kumagai M, Nagai Y. α-Silylpropionitriles: A new reagent for the synthesis of α,β-unsaturated nitriles Tetrahedron Letters. 15: 4005-4008. DOI: 10.1016/S0040-4039(01)92069-6  0.248
2013 Saito A, Higgins M, Zheng S, Li W, Ojima I, Dinkova-Kostova AT, Honda T. Synthesis and biological evaluation of biotin conjugates of (±)-(4bS,8aR,10aS)-10a-ethynyl-4b,8,8-trimethyl-3,7-dioxo-3,4b,7,8,8a,9,10,10a-octahydro-phenanthrene-2,6-dicarbonitrile, an activator of the Keap1/Nrf2/ARE pathway, for the isolation of its protein targets. Bioorganic & Medicinal Chemistry Letters. 23: 5540-3. PMID 24018193 DOI: 10.1016/J.Bmcl.2013.08.058  0.247
1982 Ojima I, Yoda N, Yatabe M. Synthesis of Enkephalin analogs via asymmetric hydrogenation of dehydropeptide building blocks Tetrahedron Letters. 23: 3917-3920. DOI: 10.1016/S0040-4039(00)87742-4  0.246
1990 Ojima I, Clos N, Donovan RJ, Ingallina P. Hydrosilylation of 1-hexyne catalyzed by rhodium and cobalt-rhodium mixed-metal complexes. Mechanism of apparent trans addition Organometallics. 9: 3127-3133. DOI: 10.1021/Om00162A026  0.244
1981 OJIMA I, KOGURE T. ChemInform Abstract: HYDROSILYLATION OF DIENES, ACETYLENES, AND CARBONYLS CATALYZED BY TRANSITION METAL COMPLEXES Chemischer Informationsdienst. 12. DOI: 10.1002/Chin.198149361  0.243
2024 Sun Y, Kim S, Shin S, Takemura K, Matos GS, Lazzarini C, Haranahalli K, Zambito J, Garg A, Del Poeta M, Ojima I. SAR study of N'-(Salicylidene)heteroarenecarbohydrazides as promising antifungal agents. Bioorganic & Medicinal Chemistry. 100: 117610. PMID 38306882 DOI: 10.1016/j.bmc.2024.117610  0.243
2012 Otová B, Ojima I, Václavíková R, Hrdý J, Ehrlichová M, Sou?ek P, Vobo?ilová J, N?mcová V, Zanardi I, Horský S, Ková? J, Gut I. Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes. Investigational New Drugs. 30: 991-1002. PMID 21448670 DOI: 10.1007/S10637-011-9654-0  0.242
1975 Kondo K, Ojima I. The Intramolecular Participation Of Sulfide Linkage On The Reactivity Of Carbenes And Diazoalkanes Part 2, Alkylcarbenes And Diazoalkanes Bearing Arylthio And Allylthio Groups On Beta-Carbon Cheminform. 6. DOI: 10.1002/Chin.197532148  0.241
1987 Ojima I, Nakahashi K, Brandstadter SM, Hatanaka N. Remarkable effects of lone pair-lone pair interactions on the extremely stereoselective [2 + 2] cycloaddition of azidoketene to chiral 3-imino-.beta.-lactams Journal of the American Chemical Society. 109: 1798-1805. DOI: 10.1021/Ja00240A033  0.24
2018 Mor V, Rella A, Farnoud AM, Singh A, Munshi M, Bryan A, Naseem S, Konopka JB, Ojima I, Bullesbach E, Ashbaugh A, Linke MJ, Cushion M, Collins M, Ananthula HK, et al. Erratum for Mor et al., "Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids". Mbio. 9. PMID 29535196 DOI: 10.1128/Mbio.00188-18  0.24
1996 Ojima I, Tzamarioudaki M, Li Z, Donovan RJ. Transition Metal-Catalyzed Carbocyclizations in Organic Synthesis. Chemical Reviews. 96: 635-662. PMID 11848768 DOI: 10.1021/Cr950065Y  0.24
1973 OJIMA I, NIHONYANAGI M, NAGAI Y. ChemInform Abstract: STEREOSELEKTIVE RED. VON KETONEN MIT HYDROSILAN-RHODIUM(I)-KOMPLEX-KOMBINATIONEN Chemischer Informationsdienst. 4: no-no. DOI: 10.1002/Chin.197310206  0.239
2018 Bogdan D, Falcone J, Kanjiya MP, Park SH, Carbonetti G, Studholme K, Gomez M, Lu Y, Elmes MW, Smietalo N, Yan S, Ojima I, Puopolo M, Kaczocha M. Fatty acid binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation. The Journal of Biological Chemistry. PMID 29440395 DOI: 10.1074/Jbc.Ra118.001593  0.239
1973 OJIMA I, KOGURE T, NIHONYANAGI M, NAGAI Y. ChemInform Abstract: RED. VON CARBONYLVERBINDUNGEN MIT VERSCHIEDENEN HYDROSILAN-RHODIUM(I)-KOMPLEX-KOMBINATIONEN Chemischer Informationsdienst. 4: no-no. DOI: 10.1002/Chin.197304156  0.239
1988 Ojima I. New aspects of carbonylations catalyzed by transition metal complexes Chemical Reviews. 88: 1011-1030. DOI: 10.1021/Cr00089A002  0.239
2018 Wang T, Zhang Y, Wei L, Teng YG, Honda T, Ojima I. Design, Synthesis, and Biological Evaluations of Asymmetric Bow-Tie PAMAM Dendrimer-Based Conjugates for Tumor-Targeted Drug Delivery. Acs Omega. 3: 3717-3736. PMID 29732446 DOI: 10.1021/acsomega.8b00409  0.238
1990 Ojima I, Komata T, Qiu X. Asymmetric alkylations of a phenylalanylglycinate equivalent. Novel route to dipeptides bearing .alpha.-alkyl-.alpha.-amino acid residues Journal of the American Chemical Society. 112: 770-774. DOI: 10.1021/Ja00158A041  0.238
2017 Peng X, Studholme K, Kanjiya MP, Luk J, Bogdan D, Elmes MW, Carbonetti G, Tong S, Gary Teng YH, Rizzo RC, Li H, Deutsch DG, Ojima I, Rebecchi MJ, Puopolo M, et al. Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms. Molecular Pain. 13: 1744806917697007. PMID 28326944 DOI: 10.1177/1744806917697007  0.238
1971 Ojima I, Onishi T, Iwamoto T, Inamoto N, Tamaru K. Syntheses of a New Series of Transition Metal Chelates of Diphenylphosphinothioylthiourea Anion Bulletin of the Chemical Society of Japan. 44: 2150-2154. DOI: 10.1246/Bcsj.44.2150  0.238
2008 Duncan R, Ojima I, Neri D, Shimma N, Okabe H, Ishitsuka H, Märki HP. Mini-symposium of the Division for Medicinal Chemistry (DMC) of the Swiss Chemical Society (SCS), at the Department of Chemistry, University of Basel, May 29, 2008 Chimia. 62: 918-934. DOI: 10.2533/chimia.2008.918  0.237
2012 Ojima I. Interview with Future Medicinal Chemistry's US Senior Editor, Iwao Ojima. Interview by Issac Bruce. Future Medicinal Chemistry. 4: 2019-22. PMID 23157234 DOI: 10.4155/Fmc.12.151  0.236
1987 Ojima I, Kato K, Okabe M, Fuchikami T. Hydroformylation of fluoro olefins, RfCH:CH2, catalyzed by group VIII transition-metal catalysts. Crucial factors for extremely high regioselectivity Journal of the American Chemical Society. 109: 7714-7720. DOI: 10.1021/Ja00259A020  0.234
2013 Saito A, Zheng S, Takahashi M, Li W, Ojima I, Honda T. An improved synthesis of a hydroxymethyl tricyclic ketone from cyclohexanone, the key processes for the synthesis of a highly potent anti-inflammatory and cytoprotective agent Synthesis (Germany). 45: 3251-3254. DOI: 10.1055/S-0033-1339900  0.234
1977 Achiwa K, Kogure T, Ojima I. Catalytic asymmetric syntheses of R(−)- and S(+)-pantolactone Tetrahedron Letters. 18: 4431-4432. DOI: 10.1016/S0040-4039(01)83528-0  0.232
1973 Ojima I, Kondo K. Chemical Evidence For The Existence Of P Pi-D Pi Interaction Between The Unsaturated Bond And The Sulfur Atom In Allyl And Vinyl Sulfide Systems Cheminform. 4. DOI: 10.1002/Chin.197344092  0.232
1991 Ojima I, Jameison FA. A new potent inhibitor for angiotensin converting enzyme: (R,S)-captopril-F3 Bioorganic & Medicinal Chemistry Letters. 1: 581-584. DOI: 10.1016/S0960-894X(01)81155-0  0.232
1973 Ojima I, Kondi K. Intramolecular Participation Of Sulfide Linkage In The Reactivity Of Carbene And Diazoalkanes Part 1, Alkylcarbenes And Diazoalkanes Bearing Alkylthio, Arylthio, And Allylthio Groups On Alpha-Carbon Cheminform. 4. DOI: 10.1002/Chin.197332154  0.232
1975 OJIMA I, KUMAGAI M, NAGAI Y. ChemInform Abstract: ALPHA-SILYLPROPIONITRILES, A NEW REAGENT FOR THE SYNTHESIS OF ALPHA,BETA-UNSATURATED NITRILES Chemischer Informationsdienst. 6: no-no. DOI: 10.1002/Chin.197507164  0.23
1980 OJIMA I. ChemInform Abstract: NEWER METHODS IN SELECTIVE AND ASYMMETRIC REDUCTIONS USING HOMOGENEOUS TRANSITION METAL CATALYSTS Chemischer Informationsdienst. 11. DOI: 10.1002/Chin.198051337  0.23
2020 Fernandes CM, Dasilva D, Haranahalli K, McCarthy JB, Mallamo J, Ojima I, Del Poeta M. The future of antifungal drug therapy: novel compounds and targets. Antimicrobial Agents and Chemotherapy. PMID 33229427 DOI: 10.1128/AAC.01719-20  0.229
1975 Kono H, Wakao N, Ojima I, Nagai Y. THE FORMATION OF SILYLRHODIUM COMPLEXES BY OXIDATIVE ADDITION OF HYDROSILANES TO HYDRIDOTETRAKIS(TRIPHENYLPHOSPHINE) RHODIUM(I). A HOMOGENEOUS CATALYST FOR HYDROSILATION Chemistry Letters. 4: 189-190. DOI: 10.1002/Chin.197544290  0.229
2009 Ojima I, Thurston DE. Welcome to Future Medicinal Chemistry Future Medicinal Chemistry. 1: 1-2. DOI: 10.4155/Fmc.09.14  0.229
2015 Mohelnikova-Duchonova B, Kocik M, Duchonova B, Brynychova V, Oliverius M, Hlavsa J, Honsova E, Mazanec J, Kala Z, Ojima I, Soucek P. Importance of hedgehog signaling pathway in pancreatic cancer treatment and prognosis Pancreatology. 15: S37. DOI: 10.1016/J.Pan.2015.05.159  0.228
1988 Ojima I, Nakahashi K, Brandstadter SM, Hatanaka N. Remarkable effects of lone pair-lone pair interactions on the extremely stereoselective [2 + 2] cycloaddition of azidoketene to chiral 3-imino-.beta.-lactams [Erratum to document cited in CA106(19):156852x] Journal of the American Chemical Society. 110: 1323-1323. DOI: 10.1021/Ja00212A068  0.227
1972 Kondo K, Ojima I. Intramolecular cycloadditions of α- and β-allylthioalkyl diazoalkanes Journal of the Chemical Society, Chemical Communications. 63-64. DOI: 10.1039/C39720000063  0.227
1994 Ojima I, Dong Q, Eguchi M, Oh Y, Amann CM, Coller BS. Structure-activity relationships of double-strand RGD peptides as GPIIb/IIIa receptor antogonists Bioorganic & Medicinal Chemistry Letters. 4: 1749-1754. DOI: 10.1016/S0960-894X(00)80374-1  0.224
1988 Ojima I, Okabe M, Kato K, Kwon HB, Horvath IT. Homogeneous catalysis of mixed-metal systems. Highly regioselective hydroformylation-amidocarbonylation of a fluoro olefin catalyzed by cobalt-rhodium mixed-metal systems. Observation of CoRh(CO)7 catalysis Journal of the American Chemical Society. 110: 150-157. DOI: 10.1021/Ja00209A024  0.224
1972 KONDO K, NEGISHI A, OJIMA I. ChemInform Abstract: SAEUREKATALYSIERTE RINGOEFFNUNGSRK. VON EPISULFOXIDEN Chemischer Informationsdienst. 3: no-no. DOI: 10.1002/Chin.197244166  0.223
1970 EMOTO T, OKAZAKI R, OJIMA I, OCHIAI T, KAWASHIMA T, NAKAYAMA S, YAMADA K, YOSHIFUJI M. ChemInform Abstract: TABELLEN FUER SYNTH. VON PHOSPHORORGANISCHEN VERBINDUNGEN Chemischer Informationsdienst. Organische Chemie. 1: no-no. DOI: 10.1002/Chin.197028008  0.223
1973 Ojima I, Inaba S, Kogure T, Matsumoto M, Matsumoto H, Watanabe H, Nagai Y. Reactions of hydropolysilanes with alcohols catalysed by tris(triphenylphosphine)chlororhodium Journal of Organometallic Chemistry. 55: C4-C6. DOI: 10.1016/S0022-328X(00)84017-6  0.223
2018 Ahmad G, Gattacecca F, El Sadda R, Botchkina G, Ojima I, Egan J, Amiji M. Biodistribution and Pharmacokinetic Evaluations of a Novel Taxoid DHA-SBT-1214 in an Oil-in-Water Nanoemulsion Formulation in Naïve and Tumor-Bearing Mice. Pharmaceutical Research. 35: 91. PMID 29520477 DOI: 10.1007/S11095-018-2349-X  0.223
1973 OJIMA I, NIHONYANAGI M, NAGAI Y. ChemInform Abstract: EIN NEUER WEG ZU SILYLTHIOAETHERN Chemischer Informationsdienst. 4: no-no. DOI: 10.1002/Chin.197324305  0.222
1970 OJIMA I, ONISHI T, IWAMOTO T, INAMOTO N, TAMARU K. ChemInform Abstract: NEUER WEG ZU UND FIR-SPEKTREN VON DIMETHYLDITHIOCARBAMATO-METALLCHELATEN Chemischer Informationsdienst. Organische Chemie. 1: no-no. DOI: 10.1002/Chin.197018381  0.222
2018 Luk J, Lu Y, Ackermann A, Peng X, Bogdan D, Puopolo M, Komatsu DE, Tong S, Ojima I, Rebecchi MJ, Kaczocha M. Contribution of diacylglycerol lipase β to pain after surgery. Journal of Pain Research. 11: 473-482. PMID 29551907 DOI: 10.2147/Jpr.S157208  0.222
1971 OJIMA I, ONISHI T, IWAMOTO T, INAMOTO N, TAMARU K. ChemInform Abstract: SYNTH. VON UEBERGANGSMETALLCHELATEN MIT DIPHENYLTHIOPHOSPHINYLTHIOHARNSTOFFEN Chemischer Informationsdienst. Organische Chemie. 2: no-no. DOI: 10.1002/Chin.197146045  0.221
1991 Ojima I, Donovan RJ, Clos N. Rhodium and cobalt carbonyl clusters Rh4(CO)12, Co2Rh2(CO)12, and Co3Rh(CO)12 as effective catalysts for hydrosilylation of isoprene, cyclohexanone, and cyclohexenone Organometallics. 10: 2606-2610. DOI: 10.1021/Om00054A020  0.22
2003 Brooks TA, Minderman H, O'Loughlin KL, Pera P, Ojima I, Baer MR, Bernacki RJ, Brooks T. Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Molecular Cancer Therapeutics. 2: 1195-205. PMID 14617793  0.22
2021 Artunduaga Bonilla JJ, Honorato L, Haranahalli K, Gremião IDF, Pereira SA, Guimarães A, Baptista ARS, de M Tavares P, Rodrigues ML, Miranda K, Ojima I, Del Poeta M, Nimrichter L. Antifungal activity of Acylhydrazone derivatives against spp. Antimicrobial Agents and Chemotherapy. PMID 33593845 DOI: 10.1128/AAC.02593-20  0.218
2021 Seborova K, Kloudova-Spalenkova A, Koucka K, Holy P, Ehrlichova M, Wang C, Ojima I, Voleska I, Daniel P, Balusikova K, Jelinek M, Kovar J, Rob L, Hruda M, Mrhalova M, et al. The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes. International Journal of Molecular Sciences. 23. PMID 35008510 DOI: 10.3390/ijms23010073  0.217
1991 Ojima I, Donovan RJ, Clos N. Rhodium and cobalt carbonyl clusters Rh4(CO)12, Co2Rh2(CO)12, and Co3Rh(CO)12 as effective catalysts for hydrosilylation of isoprene, cyclohexanone, and cyclohexenone [Erratum to document cited in CA115(13):136155e] Organometallics. 10: 3790-3790. DOI: 10.1021/Om00056A065  0.216
1981 OJIMA I. Report on the 2nd International Symposium on Homogeneous Catalysis Journal of Synthetic Organic Chemistry, Japan. 39: 415-422. DOI: 10.5059/Yukigoseikyokaishi.39.415  0.216
1970 OJIMA I, AKIBA K, INAMOTO N. ChemInform Abstract: RK. VON DIARYLPHOSPHINEN, IHREN OXIDEN UND SULFIDEN MIT ISOTHIOCYANATEN UND THIOCYANSAEURE Chemischer Informationsdienst. Organische Chemie. 1: no-no. DOI: 10.1002/Chin.197015362  0.215
1970 Ojima I, Onishi T, Iwamoto T, Inamoto N, Tamaru K. A new route to metal chelates of dimethyldithiocarbamate and their far infrared spectra Inorganic and Nuclear Chemistry Letters. 6: 65-69. DOI: 10.1016/0020-1650(70)80286-0  0.214
2022 Wang C, Aguilar A, Ojima I. Strategies for the drug discovery and development of taxane anticancer therapeutics. Expert Opinion On Drug Discovery. 1-15. PMID 36200759 DOI: 10.1080/17460441.2022.2131766  0.214
2021 Ojima I. Recent advances in tumor-targeting chemotherapy drugs. Cancer Drug Resistance (Alhambra, Calif.). 4: 885-887. PMID 35309517 DOI: 10.20517/cdr.2021.86  0.209
1995 Ojima I. Recent Advances in the .beta.-Lactam Synthon Method Accounts of Chemical Research. 28: 383-389. DOI: 10.1021/Ar00057A004  0.209
1982 Fuchikami T, Ojima I. Remarkable dependency of regioselectivity on the catalyst metal species in the hydroformylation of trifluoropropene and pentafluorostyrene Journal of the American Chemical Society. 104: 3527-3529. DOI: 10.1021/Ja00376A057  0.208
1973 Ojima I, Inaba S, Kogure T, Nagai Y. The action of tris(triphenylphosphine)chlororhodium on polyhydromonosilanes Journal of Organometallic Chemistry. 55: C7-C8. DOI: 10.1016/S0022-328X(00)84018-8  0.207
2009 Ojima I. Synthetic organic chemists at a crossroads -challenges and possibilities- Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry. 67: 1093. DOI: 10.5059/Yukigoseikyokaishi.67.1093  0.205
1973 OJIMA I, KOGURE T, NAGAI Y. ChemInform Abstract: SELEKTIVE RED. VON ALPHA,BETA-UNGESAETTIGTEN TERPEN-CARBONYLVERBINDUNGEN MIT HYDROSILAN/RHODIUM(I)-KOMPLEX-MISCHUNGEN Chemischer Informationsdienst. 4: no-no. DOI: 10.1002/Chin.197310208  0.205
2017 Ojima I. Great Challenges in Organic Chemistry. Frontiers in Chemistry. 5: 52. PMID 28748181 DOI: 10.3389/Fchem.2017.00052  0.202
2006 Varchi G, Ojima I. Synthesis of heterocycles through hydrosilylation, silylformylation, silylcarbocyclization and cyclohydrocarbonylation reactions Current Organic Chemistry. 10: 1341-1362. DOI: 10.2174/138527206778018230  0.201
1990 Ojima I, Zhang Z. Mechanism of amidocarbonylation: a stereochemical approach Organometallics. 9: 3122-3127. DOI: 10.1021/Om00162A025  0.198
1983 Ojima I. Book Reviews: Topics in Current Chemistry. Vol 105. Organic Chemistry Organometallics. 2: 941-941. DOI: 10.1021/Om50001A038  0.197
2002 Chin T, Sawamura S, Fujita H, Ojima I, Oyabu H, Nagakura Y, Otsuka H, Nakagawa A. %VO2max as an indicator of prosthetic rehabilitation outcome after dysvascular amputation Prosthetics and Orthotics International. 26: 44-49. PMID 12043925 DOI: 10.1080/03093640208726620  0.197
2009 Ojima I. Fluorine in Medicinal Chemistry and Chemical Biology Fluorine in Medicinal Chemistry and Chemical Biology. 1-624. DOI: 10.1002/9781444312096  0.195
1999 Ferlini C, Distefano M, Pierelli L, Bonanno G, Riva A, Bombardelli E, Ojima I, Mancuso S, Scambia G. Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127 Oncology Research. 11: 471-478. PMID 10850888  0.191
2010 OJIMA I, TZAMARIOUDAKI M, EGUCHI M. ChemInform Abstract: New and Efficient Route to Pipecolic Acid Derivatives by Means of Rh- Catalyzed Intramolecular Cyclohydrocarbonylation. Cheminform. 27: no-no. DOI: 10.1002/chin.199612165  0.191
2021 Haranahalli K, Tong S, Kim S, Awwa M, Chen L, Knudson SE, Slayden RA, Singleton E, Russo R, Connell N, Ojima I. Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting -FtsZ as antitubercular agents. Rsc Medicinal Chemistry. 12: 78-94. PMID 34046600 DOI: 10.1039/d0md00256a  0.191
1999 Chin T, Sawamura S, Fujita H, Nakajima S, Ojima I, Oyabu H, Nagakura Y, Otsuka H, Nakagawa A. The efficacy of physiological cost index (PCI) measurement of a subject walking with an Intelligent Prosthesis Prosthetics and Orthotics International. 23: 45-49. PMID 10355642 DOI: 10.3109/03093649909071609  0.19
2010 Ojima I, Moralee AC, Vassar VC. ChemInform Abstract: Recent Advances in Rhodium-Catalyzed Cyclization Reactions Cheminform. 33: no-no. DOI: 10.1002/chin.200252269  0.188
2010 ZHANG Z, OJIMA I. ChemInform Abstract: Syntheses of Nitrogen Heterocycles by Means of Amine-Directed Carbonylation and Hydrocarbonylation. Cheminform. 24: no-no. DOI: 10.1002/chin.199347083  0.186
1997 Chin T, Sawamura S, Fujita H, Nakajima S, Ojima I, Oyabu H, Nagakura Y, Nakagawa A. The efficacy of the one-leg cycling test for determining the anaerobic threshold (AT) of lower limb amputees Prosthetics and Orthotics International. 21: 141-146. PMID 9285958 DOI: 10.3109/03093649709164542  0.185
2021 Wang M, Wang C, Feng C, Guo W, Chen H, Liu B, Li E, Liu W, Taouil A, Ojima I, Hou P. Potent antitumor activity of novel taxoids in anaplastic thyroid cancer. Endocrine. PMID 34591230 DOI: 10.1007/s12020-021-02880-1  0.182
2004 Brooks TA, Kennedy DR, Gruol DJ, Ojima I, Baer MR, Bernacki RJ. Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators. Anticancer Research. 24: 409-15. PMID 15152938  0.177
2007 Ojima I. Editorial Current Topics in Medicinal Chemistry. 7: 457. DOI: 10.2174/156802607780059754  0.176
1996 Ojima I. Taxol®: Science and Applications Edited by Matthew Suffness. CRC Press, Boca Raton, FL. 1995. 426 pp. 18.5 × 26 cm. ISBN 0-8493-8382-X. $129.95. Journal of Medicinal Chemistry. 39: 807-807. DOI: 10.1021/Jm950752H  0.173
2010 OJIMA I, HABUS I, ZHAO M, GEORG GI, JAYASINGHE LR. ChemInform Abstract: Efficient and Practical Asymmetric Synthesis of the Taxol C-13 Side Chain, N-Benzoyl-(2R,3S)-3-phenylisoserine, and Its Analogues via Chiral 3-Hydroxy-4-aryl-β-lactams Through Chiral Ester Enolate. Cheminform. 22: no-no. DOI: 10.1002/chin.199130137  0.172
2023 Hillowe A, Gordon C, Wang L, Rizzo RC, Trotman LC, Ojima I, Bialkowska A, Kaczocha M. Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells. Plos One. 18: e0292483. PMID 37796964 DOI: 10.1371/journal.pone.0292483  0.17
2023 Zhu C, Schutz L, Jayanetti K, Takemura K, Doswell F, Wang L, Ojima I, Kaczocha M. Truxillic acid monoamides as fatty acid binding protein 5 inhibitors. Bioorganic & Medicinal Chemistry. 94: 117464. PMID 37708641 DOI: 10.1016/j.bmc.2023.117464  0.17
2010 OJIMA I, KASS DF, ZHU J. ChemInform Abstract: New and Efficient Catalytic Route to Bicyclo(3.3.0)octa-1,5-dien-3- ones. Cheminform. 28: no-no. DOI: 10.1002/chin.199712081  0.166
1998 Ojima I. Asymmetric Synthesis.Garry Procter The Quarterly Review of Biology. 73: 492-492. DOI: 10.1086/420437  0.166
2010 OJIMA I, FRACCHIOLLA DA, DONOVAN RJ, BANERJI P. ChemInform Abstract: Silylcarbobicyclization of 1,6-Diynes: A Novel Catalytic Route to Bicyclo(3.3.0)octenones. Cheminform. 26: no-no. DOI: 10.1002/chin.199524080  0.165
2010 OJIMA I, HABUS I. ChemInform Abstract: Asymmetric Synthesis of β-Lactams by Chiral Ester Enolate-Imine Condensation. Cheminform. 22: no-no. DOI: 10.1002/chin.199134155  0.163
2005 Fujiwara M, Ojima I. Rhodium(I)-Catalyzed Cycloisomerization and Cyclotrimerization Reactions Modern Rhodium-Catalyzed Organic Reactions. 129-149. DOI: 10.1002/3527604693.ch7  0.162
2010 OJIMA I, DONOVAN RJ, SHAY WR. ChemInform Abstract: Silylcarbocyclization Reactions Catalyzed by Rh and Rh-Co Complexes. Cheminform. 23: no-no. DOI: 10.1002/chin.199245220  0.161
2022 Morales D, Micheva-Viteva S, Adikari S, Werner J, Wolinsky M, Hong-Geller E, Kim J, Ojima I. Targeting the Bet-Hedging Strategy with an Inhibitor of Bacterial Efflux Capacity Enhances Antibiotic Efficiency and Ameliorates Bacterial Persistence In Vitro. Microorganisms. 10. PMID 36296242 DOI: 10.3390/microorganisms10101966  0.16
1987 OJIMA I. ChemInform Abstract: Novel Synthetic Routes to Organofluorine Compounds of Biological Interest Cheminform. 18. DOI: 10.1002/chin.198742369  0.158
2024 Sychra T, Spalenkova A, Balatka S, Vaclavikova R, Seborova K, Ehrlichova M, Truksa J, Sandoval-Acuña C, Nemcova V, Szabo A, Koci K, Tesarova T, Chen L, Ojima I, Oliverius M, et al. Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma. Iscience. 27: 109044. PMID 38357661 DOI: 10.1016/j.isci.2024.109044  0.158
2009 Kovár J, Ehrlichová M, Smejkalová B, Zanardi I, Ojima I, Gut I. Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells. Anticancer Research. 29: 2951-60. PMID 19661300  0.157
2021 Deng J, Yang Z, Ojima I, Samaras D, Wang F. Artificial intelligence in drug discovery: applications and techniques. Briefings in Bioinformatics. PMID 34734228 DOI: 10.1093/bib/bbab430  0.154
1979 OJIMA I, INABA S. ChemInform Abstract: KETENE SILYL ACETALS. NEW VERSATILE REAGENTS FOR ORGANIC SYNTHESIS Chemischer Informationsdienst. 10. DOI: 10.1002/chin.197901390  0.153
2006 Ojima I. Discovery and Development of New Generation Taxane Anticancer Agents Cheminform. 37. DOI: 10.1002/chin.200607287  0.153
2023 M Swamynathan M, Mathew G, Aziz A, Gordon C, Hillowe A, Wang H, Jhaveri A, Kendall J, Cox H, Giarrizzo M, Azabdaftari G, Rizzo RC, Diermeier SD, Ojima I, Bialkowska AB, et al. FABP5 Inhibition against -Mutant Therapy Resistant Prostate Cancer. Cancers. 16. PMID 38201488 DOI: 10.3390/cancers16010060  0.153
1999 Ojima I, Inoue T, Slater JC, Lin S, Kuduk SD, Chakravarty S, Walsh JJ, Cresteil T, Monsarrat B, Pera P, Bernacki RJ. Synthesis of enatiopure fluorine-containing taxoids and their use as anticancer agents as well as probes for biomedical problems Acs Symposium Series. 746: 158-181.  0.151
1988 OJIMA I, QIU X. ChemInform Abstract: Asymmetric Alkylation of Chiral β-Lactam Ester Enolates. A New Approach to the Synthesis of α-Alkylated α-Amino Acids. Cheminform. 19. DOI: 10.1002/chin.198806292  0.15
2010 Ojima I, Li Z, Zhu J. ChemInform Abstract: Recent Advances in Hydrosilylation and Related Reactions Cheminform. 30: no-no. DOI: 10.1002/chin.199915340  0.145
2010 OJIMA I, KUDUK SD, SLATER JC, GIMI RH, SUN CM, CHAKRAVARTY S, OUREVITCH M, ABOUABDELLAH A, BONNET-DELPON D, ET AL. EA. ChemInform Abstract: Syntheses, Biological Activity, and Conformational Analysis of Fluorine-Containing Taxoids Cheminform. 28: no-no. DOI: 10.1002/chin.199708256  0.144
2022 Seborova K, Koucka K, Spalenkova A, Holy P, Ehrlichova M, Sychra T, Chen L, Bendale H, Ojima I, Sandoval-Acuña C, Truksa J, Soucek P, Vaclavikova R. Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model. Frontiers in Pharmacology. 13: 971905. PMID 36438837 DOI: 10.3389/fphar.2022.971905  0.142
1990 OJIMA I, KATO K, NAKAHASHI K, FUCHIKAMI T, FUJITA M. ChemInform Abstract: New and Effective Routes to Fluoro Analogues of Aliphatic and Aromatic Amino Acids. Cheminform. 21. DOI: 10.1002/chin.199008312  0.14
2023 Daniel P, Balušíková K, Václavíková R, Šeborová K, Ransdorfová Š, Valeriánová M, Wei L, Jelínek M, Tlapáková T, Fleischer T, Kristensen VN, Souček P, Ojima I, Kovář J. Amplicon Contains Cyclic AMP Response Element-Driven Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines. Genes. 14. PMID 36833223 DOI: 10.3390/genes14020296  0.139
2010 OJIMA I, TZAMARIOUDAKI M, TSAI C. ChemInform Abstract: Extremely Chemoselective Silylformylation and Silylcarbocyclization of Alkynals. Cheminform. 25: no-no. DOI: 10.1002/chin.199434092  0.139
2010 OJIMA I, DONG Q. ChemInform Abstract: Synthesis of Fluorine-Containing Amino Acids by Means of Homogeneous Catalysis Cheminform. 27: no-no. DOI: 10.1002/chin.199603296  0.138
1999 Ojima I. Designin to treat multidrug-resistant tumors Modern Drug Discovery. 2: 45-52.  0.136
2010 OJIMA I, WANG H, WANG T, NG EW. ChemInform Abstract: New Approaches to the Asymmetric Synthesis of Dipeptide Isosteres via β-Lactam Synthon Method. Cheminform. 29: no-no. DOI: 10.1002/chin.199821189  0.135
2023 Pereira de Sa N, Jayanetti K, Rendina D, Clement T, Soares Brauer V, Mota Fernandes C, Ojima I, Airola MV, Del Poeta M. Targeting Sterylglucosidase A to Treat Aspergillus fumigatus Infections. Mbio. e0033923. PMID 36877042 DOI: 10.1128/mbio.00339-23  0.133
1999 Ojima I, Kuduk SD, Chakravarty S. Recent advances in the medicinal chemistry of taxoid anticancer agents Advances in Medicinal Chemistry. 4: 69-124. DOI: 10.1016/S1067-5698(99)80004-2  0.133
2021 Pereira de Sa N, Taouil A, Kim J, Clement T, Hoffmann RM, Burke JE, Rizzo RC, Ojima I, Del Poeta M, Airola MV. Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents. Nature Communications. 12: 5885. PMID 34620873 DOI: 10.1038/s41467-021-26163-5  0.132
1972 Ojima I, Kogure T. Selective reduction of α,β-unsaturated terpene carbonyl compounds using hydrosilane-rhodium(I) complex combinations Tetrahedron Letters. 13: 5035-5038. DOI: 10.1016/S0040-4039(01)85162-5  0.128
1985 OJIMA I, HIRAI K, FUJITA M, FUCHIKAMI T. ChemInform Abstract: NEW SYNTHETIC ROUTE TO N-ACYL α-AMINO ACIDS VIA AMIDOCARBONYLATION BY MEANS OF HOMOGENEOUS BINARY CATALYST SYSTEMS Chemischer Informationsdienst. 16. DOI: 10.1002/chin.198522149  0.127
2010 OJIMA I, HABUS I, ZHAO M, ZUCCO M, PARK YH, SUN CM, BRIGAUD T. ChemInform Abstract: New and Efficient Approaches to the Semisynthesis of Taxol and Its C- 13 Side Chain Analogues by Means of β-Lactam Synthon Method. Cheminform. 23: no-no. DOI: 10.1002/chin.199250259  0.126
1998 Ojima I, Bounaud PY, Bernacki RJ. New weapons in the fight against cancer Chemtech. 28: 31-36.  0.126
2007 Ojima I, Kuznetsova L, Ungureanu IM, Pepe A, Zanardi I, Chen J. Fluoro-β-lactams as Useful Building Blocks for the Synthesis of Fluorinated Amino Acids, Dipeptides, and Taxoids Cheminform. 38. DOI: 10.1002/chin.200720244  0.125
2010 OJIMA I, LI Z. ChemInform Abstract: Catalytic Activity of Rh, Rh-Co, and Ir-Co Multinuclear Complexes and Application to Organic Syntheses Cheminform. 29: no-no. DOI: 10.1002/chin.199826334  0.124
2024 Dib Ferreira Gremião I, Pereira-Oliveira GR, Pereira SA, Corrêa ML, Borba-Santos LP, Viçosa AL, Garg A, Haranahalli K, Dasilva D, Pereira de Sa N, Matos GS, Silva V, Lazzarini C, Fernandes CM, Miranda K, ... ... Ojima I, et al. Combination therapy of itraconazole and an acylhydrazone derivative (D13) for the treatment of sporotrichosis in cats. Microbiology Spectrum. e0396723. PMID 38647345 DOI: 10.1128/spectrum.03967-23  0.12
1971 OJIMA I, INAMOTO N. ChemInform Abstract: 1,2-CYCLOADDITION VON PHOSPHINOTHIOYL- UND SULFONYL-ISOTHIOCYANATEN MIT CARBODIIMIDEN Chemischer Informationsdienst. Organische Chemie. 2: no-no. DOI: 10.1002/chin.197111011  0.119
1987 OJIMA I. ChemInform Abstract: Homogeneous Mixed-Metal Catalyst Systems: New and Effective Routes to N-Acyl-α-amino Acids via Carbonylations Cheminform. 18. DOI: 10.1002/chin.198742346  0.119
1975 Ojima I, Nihonyanagi M, Kogure T, Kumagai M, Horiuchi S, Nakatsugawa K, Nagai Y. Reduction of carbonyl compounds via hydrosilylation Journal of Organometallic Chemistry. 94: 449-461. DOI: 10.1016/s0022-328x(00)86954-5  0.115
1973 KONO H, OJIMA I, MATSUMOTO M, NAGAI Y. ChemInform Abstract: A CONVENIENT ROUTE TO AMINOSILANES USING HYDROSILANE-RHODIUM(I) COMPLEX COMBINATIONS Chemischer Informationsdienst. 4: no-no. DOI: 10.1002/chin.197350373  0.114
Hide low-probability matches.